Vessel detection and apposition checks for multi-organ denervation
The multi-organ denervation system uses electrode feedback to differentiate between renal and hepatic arteries, enhancing safety and precision in RF ablation by applying the correct treatment algorithm, addressing the challenge of accurate catheter location determination.
Patent Information
- Application Number
- PCT/EP2026/063280
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-08
- Filing Date
- 2026-05-07
- Publication Date
- 2026-11-12
AI Technical Summary
Existing medical catheter systems face challenges in accurately determining the location within the renal or hepatic artery to apply appropriate RF ablation treatment algorithms, leading to potential safety risks and inefficiencies.
A multi-organ denervation system uses temperature and impedance feedback from catheter electrodes to differentiate between renal and hepatic arteries, employing algorithms trained via machine learning to select the correct treatment protocol based on real-time feedback.
Enhances the safety and precision of RF ablation procedures by ensuring the appropriate treatment algorithm is applied, reducing the risk of incorrect energy delivery and improving procedural outcomes.
Smart Images

Figure EP2026063280_12112026_PF_FP_ABST
Abstract
Description
A0013546W001VESSEL DETECTION AND APPOSITION CHECKS FOR MULTI-ORGAN DENERVATION
[0001] This application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 802,134, filed May 8, 2025, the entire content of which is incorporated herein by reference.TECHNICAL FIELD
[0002] The present disclosure relates to medical catheters.BACKGROUND
[0003] A medical catheter including electrodes may be used for therapeutic applications, such as ablation applications, electrical simulation therapy, and the like.SUMMARY
[0004] In general, aspects of this disclosure describe techniques for assessing the location and apposition of a medical catheter for multi-organ denervation based on the temperature and / or impedance of electrodes of the catheter. A multi-organ denervation system includes a medical catheter (e.g., a neuromodulation catheter) to deliver RF energy through the walls of the renal arteries and common hepatic artery to denervate the kidney and liver of a patient. The system may use different treatment algorithms for RF ablation of different arteries, such as by using different treatment algorithms for treating the renal arteries and the common hepatic artery. While this disclosure describes techniques using RF ablation for the purposes of illustration, the techniques described herein are equally applicable to other ablation techniques or to techniques generally related to delivery of therapeutic treatments using a catheter.
[0005] In order to select the appropriate treatment algorithm for RF delivery, the system may detect the vessel in which the catheter is located. If the system detects that the catheter is in a renal artery, the system may select a renal treatment algorithm for delivering RF energy to treat the renal artery. If the system detects that the catheter is in a hepatic artery, the system may select a hepatic treatment algorithm for delivering RF energy to treat the hepatic artery.
[0006] In accordance with aspects of this disclosure, a multi-organ denervation system may detect the vessel in which the neuromodulation catheter of the system is located based onA0013546W001the temperature and / or impedance of electrodes of the catheter. The system may measure the temperature and / or impedance prior to and / or after initiation of RF delivery to detect the catheter location in order to select the appropriate treatment algorithm for RF delivery. In some examples, the system may measure the impedances of the electrodes of the catheter in a time period immediately prior to the electrodes initiating RF delivery. The system may measure monopolar impedances of the electrodes of the catheter or bipolar impedances between pairs of electrodes of the catheter, and / or may perform cyclical low-power frequency sweeps while measuring the impedances of the electrodes. In some examples, the system may measure the impedances of the electrodes through different return electrode monitoring pads. The system may determine, based on the measured impedances of the electrodes during the time period immediately prior to the electrodes initiating RF delivery, whether the catheter is located in the renal artery or the hepatic artery.
[0007] In some examples, the system may, during initial ramp of RF energy at the initiation of RF delivery by the electrodes, measure the temperature feedback and / or impedance feedback of the electrodes of the catheter to determine whether the catheter is located in the renal artery or the hepatic artery. For example, the system may, based on the measured temperatures of the electrodes during the initial ramp of RF energy, determine temperature data such as the average temperature of each of the electrodes during the initial ramp of RF energy, the increase in temperature of each of the electrodes during the initial ramp of RF energy, the rate of temperature increase of each of the electrodes during the initial ramp of RF energy.
[0008] The system may be able to determine, based on the temperature data for each of the electrodes during the initial ramp of RF energy, whether the catheter is located in the renal artery or the hepatic artery. In some examples, the system may also determine changes in impedance values for each of the electrodes during the initial ramp of RF energy, and may be able to determine, based on the temperature data for each of the electrodes and the changes in impedance values for each of the electrodes during the initial ramp of RF energy, whether the catheter is located in the renal artery or the hepatic artery.
[0009] In some examples, the system may cause the catheter to output a short RF pulse (or another energy pulse) prior to initiating delivery of RF energy, and the system may measure the temperature feedback and / or impedance feedback of the electrodes of the catheter during and after the RF pulse to determine, based on changes in the impedances and / or temperatures of the electrodes during and after the RF pulse, whether the catheter is located in the renal artery or the hepatic artery. For example, the system may determine, for each of theA0013546W001electrodes, temperature information such as the rate of temperature change (e.g., increase or decrease) from during the RF pulse to after the RF pulse and / or the magnitude of the temperature change. The system may also determine, for each of the electrodes, the change in impedance from during the RF pulse to after the RF pulse. The system may determine, based on the changes in temperatures of the electrodes and / or the changes in impedances of the electrodes, whether the catheter is located in the renal artery or the hepatic artery.
[0010] In some aspects, the techniques described herein relate to a method including: receiving, by processing circuitry, at least one of temperature feedback or impedance feedback associated with electrodes of a catheter; determining, by the processing circuitry and based on at least one of the temperature feedback or the impedance feedback, a location of the catheter within the patient; selecting, by the processing circuitry and based on the location of the catheter, a treatment algorithm for delivering therapeutic ablation; and controlling, by the processing circuitry, the electrodes of the catheter to deliver the therapeutic ablation according to the treatment algorithm.
[0011] In some aspects, the techniques described herein relate to a system including: memory; processing circuitry configured to: receive at least one of temperature feedback or impedance feedback associated with electrodes of a catheter; determine, based on at least one of the temperature feedback or the impedance feedback, a location of the catheter within the patient; select, based on the location of the catheter, a treatment algorithm for delivering therapeutic ablation; and control the electrodes of the catheter to deliver the therapeutic ablation according to the treatment algorithm.
[0012] In some aspects, the techniques described herein relate to an apparatus including: means for receiving at least one of temperature feedback or impedance feedback associated with electrodes of a catheter; means for determining, based on at least one of the temperature feedback or the impedance feedback, a location of the catheter within the patient; means for selecting, based on the location of the catheter, a treatment algorithm for delivering therapeutic ablation; and means for controlling the electrodes of the catheter to deliver the therapeutic ablation according to the treatment algorithm.
[0013] In some aspects, the techniques described herein relate to a non-transitory computer readable storage medium comprising instructions that, when executed by processing circuitry, cause the processing circuitry to: receive at least one of temperature feedback or impedance feedback associated with electrodes of a catheter; determine, based on at least one of the temperature feedback or the impedance feedback, a location of the catheter within the patient; select, based on the location of the catheter, a treatment algorithm for deliveringA0013546W001therapeutic ablation; and control the electrodes of the catheter to deliver the therapeutic ablation according to the treatment algorithm.
[0014] Further disclosed herein is a multi-organ denervation system that may receive at least one of temperature feedback or impedance feedback associated with electrodes of a catheter, wherein the system may determine, based on at least one of the temperature feedback or the impedance feedback, a location of the catheter within the patient, wherein the system may select, based on the location of the catheter, a treatment algorithm for delivering therapeutic ablation, and wherein the system may control the electrodes of the catheter to deliver the therapeutic ablation according to the treatment algorithm.
[0015] The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims.BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Reference is made to the attached drawings, wherein elements having the same reference numeral designations represent similar elements throughout and wherein:
[0017] FIG. 1 illustrates an example system for determining the location of a catheter within a patient.
[0018] FIG. 2 illustrates example energy pulses that can be used to determine the location of a medical catheter, in accordance with aspects of this disclosure.
[0019] FIG. 3 is a flow diagram illustrating an example technique for determining the location of a catheter using an RF pulse, in accordance with aspects of this disclosure.
[0020] FIG. 4 is a flow diagram illustrating an example technique for determining the location of a catheter based on feedback during an initial ramp of energy delivery, in accordance with aspects of this disclosure.
[0021] FIG. 5 is a flow diagram illustrating an example technique for determining the location of a catheter based on feedback measured prior to the start of therapeutic ablation, in accordance with aspects of this disclosure.
[0022] FIG. 6 is a flow diagram illustrating an example technique for determining the location of a catheter, in accordance with aspects of this disclosure.A0013546W001
[0023] FIG. 7 is a flow diagram illustrating an example technique for determining the location of a catheter based on feedback during an initial ramp of energy delivery, in accordance with aspects of this disclosure.
[0024] FIG. 8 is a flow diagram illustrating an example technique for determining the location of a catheter based on feedback measured prior to the start of therapeutic ablation, in accordance with aspects of this disclosure.
[0025] FIG. 9 is a flow diagram illustrating an example technique for determining the catheter for performing ablation therapy, in accordance with aspects of this disclosure.
[0026] FIG. 10 is a flow diagram illustrating an example technique for determining the catheter for performing ablation therapy, in accordance with aspects of this disclosure.
[0027] FIG. 11 is a flow diagram illustrating an example technique for determining the location of a catheter.
[0028] FIG. 12 illustrates an example technique for accessing a renal artery and modulating renal nerves with a neuromodulation catheter in accordance with some examples of the present disclosure.
[0029] FIG. 13 is a conceptual illustration of an example sympathetic nervous system (SNS) illustrating how the brain communicates with the body via the SNS.
[0030] FIG. 14 is an enlarged anatomic view of nerves innervating a left kidney to form the renal plexus surrounding the left renal artery.
[0031] FIG. 15 is an anatomic view of a human body depicting neural efferent and afferent communication between the brain and kidneys.
[0032] FIG. 16 is a conceptual view of a human body depicting neural efferent and afferent communication between the brain and kidneys.
[0033] FIG. 17 is an anatomic view of the arterial vasculature of a human.
[0034] FIG. 18 is an anatomic view of the venous vasculature of a human.DETAILED DESCRIPTION
[0035] Medical catheters include electrodes used to deliver therapy, such as ablation therapy. For example, the electrodes may deliver high-frequency electrical current to targeted tissue to destroy or damage the tissue in a controlled manner to treat a variety of medical conditions, such as high blood pressure, abnormal heart rhythms, tumors, or chronic pain. The electrodes may be disposed on any suitable portion of an elongated member of a catheter, and the catheter is configured to electrically connect the electrodes to a medical device, whichA0013546W001may deliver electrical signals and / or radio frequency signals to a tissue site within a patient via one or more of the electrodes.
[0036] A renal denervation system may use a multi-electrode renal denervation catheter, such as Symplicity Spyral™ Multi -El ectrode Renal Denervation Catheter, along with a generator, such as the Symplicity G3 ™ Generator, each of which was or is available from Medtronic Inc., of Minneapolis, to Mdeliver radiofrequency (RF) energy through walls of the renal arteries to denervate the human kidney. Increasingly, a multi-organ denervation system may use such a renal denervation catheter not only for renal denervation but also for multiorgan denervation, such as to deliver RF energy through walls of the common hepatic artery to denervate the human liver.
[0037] A multi-organ denervation system may use different treatment algorithms for RF ablation of different arteries, such as by using different treatment algorithms for treating the renal arteries and the common hepatic artery. For example, the system may use a renal treatment algorithm to deliver RF frequency in the renal arteries, and may use a hepatic treatment algorithm to deliver RF frequency in the hepatic artery.
[0038] In order to increase the safety of such a system, such as to prevent the system from using a renal treatment algorithm to deliver RF energy in the hepatic artery or to prevent the system from using a hepatic treatment algorithm to deliver RF energy in the renal artery, aspects of this disclosure describe techniques for determining the location of a medical catheter for multi-organ denervation within a patient based on the temperatures and / or impedances of the electrodes of the catheter. The system may be able to determine, based on the temperatures and / or impedances of the electrodes of the catheter, whether the catheter is located in the renal artery of the patient or in the hepatic artery of the patient. The system may therefore be able to select, based on the location of the catheter, the appropriate treatment algorithm to deliver RF energy.
[0039] The system may measure the temperatures and / or impedances of the electrodes prior to and / or after initiation of RF delivery to detect the catheter location in order to select the appropriate treatment algorithm for RF delivery. In some examples, the system may measure the impedances of the electrodes of the catheter in a time period immediately prior to the electrodes initiating RF delivery. The system may measure monopolar impedances of the electrodes of the catheter or bipolar impedances between pairs of electrodes of the catheter, and / or may perform cyclical low-power frequency sweeps while measuring the impedances of the electrodes. In some examples, the system may measure the impedances of the electrodes through different return electrode monitoring pads. The system may determine, based on theA0013546W001measured impedances of the electrodes during the time period immediately prior to the electrodes initiating RF delivery, whether the catheter is located in the renal artery or the hepatic artery.
[0040] In some examples, the system may, during initial ramp of RF energy at the initiation of RF delivery by the electrodes, measure the temperature feedback and / or impedance feedback of the electrodes of the catheter to determine whether the catheter is located in the renal artery or the hepatic artery. For example, the system may, based on the measured temperatures of the electrodes during the initial ramp of RF energy, determine temperature data such as the average temperature of each of the electrodes during the initial ramp of RF energy, the increase in temperature of each of the electrodes during the initial ramp of RF energy, the rate of temperature increase of each of the electrodes during the initial ramp of RF energy.
[0041] The system may be able to determine, based on the temperature data for each of the electrodes during the initial ramp of RF energy, whether the catheter is located in the renal artery or the hepatic artery. In some examples, the system may also determine changes in impedance values for each of the electrodes during the initial ramp of RF energy, and may be able to determine, based on the temperature data for each of the electrodes and the changes in impedance values for each of the electrodes during the initial ramp of RF energy, whether the catheter is located in the renal artery or the hepatic artery.
[0042] In some examples, the system may cause the catheter to output a short RF pulse prior to initiating delivery of RF energy, and the system may measure the temperature feedback and / or impedance feedback of the electrodes of the catheter during and after the RF pulse to determine, based on changes in the impedances and / or temperatures of the electrodes during and after the RF pulse, whether the catheter is located in the renal artery or the hepatic artery. For example, the system may determine, for each of the electrodes, temperature information such as the rate of temperature change from during the RF pulse to after the RF pulse and / or the magnitude of the temperature change. The system may also determine, for each of the electrodes, the change in impedance from during the RF pulse to after the RF pulse. The system may determine, based on the changes in temperatures of the electrodes and / or the changes in impedances of the electrodes, whether the catheter is located in the renal artery or the hepatic artery.
[0043]
[0044] FIG. 1 illustrates an example system 100 for determining the location of a catheter within a patient. As shown in FIG. 1, system 100 includes catheter 112 coupled to generatorA0013546W001and sensing device 150. Catheter 112 includes electrodes 122A-122D (“electrodes 122”) used to deliver therapy, such as ablation therapy, to a target tissue site, such as an organ tissue, arterial walls, venous walls, or other structures of a patient. In some examples, catheter 112 may include a hub portion 118 coupled to a proximal portion of elongated member 116 of catheter 112. Electrodes 122 may be disposed in any arrangement on elongated member 116. In some examples, electrodes 122 are positioned at a distal portion of elongated member 116, as shown in FIG. 1. In other examples, electrodes 122 may be positioned elsewhere on elongated member 116. While FIG. 1 illustrates catheter 112 having four electrodes 122A-122D, catheter 112 may, in other examples, include any other number of electrodes, such as five, six, seven, or eight electrodes.
[0045] Catheter 112 (e.g., via elongated member 116) may include at least one electrical conductor for electrically coupling electrodes 122 to generator and sensing device 150. In some examples, each electrode of electrodes 122 may be coupled to a respective electrical conductor. In other examples, two or more electrodes of electrodes 122 may be electrically coupled to the same electrical conductor. Thus, catheter 112 is configured to receive one or more electrical signals from generator and sensing device 150 and to deliver the electrical signal to a tissue site via one or more of electrodes 122.
[0046] Generator and sensing device 150 is configured to generate and deliver an electrical signal (for example, via a least one electrical conductor within elongated member 116) to one or more of electrodes 122, so that electrodes 122 may deliver energy to a target tissue site within a patient. The energy may include electrical energy, radiofrequency (RF) energy, pulsed electrical energy, thermal energy, or the like. Electrodes 122 may deliver therapy to the target tissue site of the patient. Such therapy may include electrical stimulation therapy, such as cardiac therapy or neurostimulation therapy, ablation, or denervation, such as renal denervation or multi-organ denervation. Generator and sensing device 150 may include any suitable medical device and / or computing device configured to generate and deliver an electrical signal that may provide therapeutic benefits to a patient, such as an ablation device, a neurostimulation device, a cardiac stimulation device, or another electrical stimulation device.
[0047] A temperature sensor, such as a thermocouple or a thermistor, may be embedded in each of electrodes 122 to measure the temperature at or very near the electrode-tissue interface. Catheter 112 may transmit electrical signals indicative of the temperatures measured by each of the temperature sensors from the temperature sensors embedded inA0013546W001electrodes 122 to generator and sensing device 150, thereby providing temperature feedback for each of electrodes 122 to generator and sensing device 150.
[0048] In some examples, generator and sensing device 150 includes an electrical source, for example, an RF energy generator. Generator and sensing device 150 is configured to generate a selected form and magnitude of energy for delivery to the target treatment site via electrodes 122. For example, generator and sensing device 150 may include a processing circuitry 152 configured to select one or more of electrodes 122 from which electrical signals are delivered, and may include drive circuitry 158 for electrically driving electrodes 122. Drive circuitry 158 may amplify or send electrical signals from processing circuitry 152 to electrodes 122.
[0049] Generator and sensing device 150 may include a memory 154. Memory 154 includes computer-readable instructions that, when executed by processing circuitry 152, causes generator and sensing device 150 to perform various functions. Processing circuitry 152 may include any one or more microprocessors, controllers, digital signal processors (DSPs), application specific integrated circuits (ASICs), field-programmable gate arrays (FPGAs), or equivalent discrete or integrated digital or analog logic circuitry, and the functions attributed to processing circuitry 152 herein may be embodied as software, firmware, hardware or any combination thereof.
[0050] Memory 154 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital media. Memory 154 may store any suitable information, including patient identification information, and information for selecting one or more electrodes through which generator and sensing device 150 generates and delivers therapy to a patient. Memory 154 may also store operating instructions with which processing circuitry 152 controls the operation of generator and sensing device 150.
[0051] Memory 154 may store program instructions, such as neural network algorithms. The program instructions may include one or more program modules that are executable by processing circuitry 152. For example, memory 154 may store catheter location model 124, which may be a model trained via machine learning to determine the location of catheter 112 in the patient. When executed by processing circuitry 152, such program instructions, such as program instructions of catheter location model 124, may cause processing circuitry 152 to provide the functionality ascribed to it herein. The program instructions may be embodied in software, firmware, and / or RAMware.A0013546W001
[0052] In some examples, electrodes 122 are configured to be electrically connected to a medical device in series or in parallel. When connected in series, e.g., via respective electrical conductors, therapy generator and sensing device 150 may deliver electrical signals via all the electrodes of electrodes 122 or via a selected subset of electrodes of electrodes 122, which can include one electrode or multiple electrodes. In some examples, processing circuitry 152 of therapy generator and sensing device 150 may be configured to select a subset of electrodes 122 for delivery of electrical energy, and may make the selection in response to user input or in response to a predetermined therapy program stored by memory. When connected in parallel, therapy generator and sensing device 150 may deliver an electrical signal via all the electrodes of electrodes 122 simultaneously.
[0053] In some examples, catheter 112 includes at least a first electrical conductor and a second electrical conductor. The first and the second electrical conductors may extend within elongated member 116 from a proximal portion of catheter 112 to electrodes 122. The first electrical conductor may be configured to deliver a first electrical signal from therapy generator and sensing device 150 to at least one of electrodes 122. The second electrical conductor may be configured to deliver a second electrical signal from therapy generator and sensing device 150 to at least one of electrodes 122.
[0054] In some examples, catheter 112 may include a plurality of electrical conductors extending within elongated member 116 from a proximal portion of catheter 112 to electrodes 122. The plurality of electrical conductors may include the first electrical conductor and the second electrical conductor. Each electrical conductor of the plurality of electrical conductors may be configured to deliver a respective electrical signal of a plurality of electrical signals from therapy generator and sensing device 150 to a respective electrode of electrodes 122. The plurality of electrical signals may include the first electrical signal and the second electrical signal.
[0055] Electrodes 122 may be carried by or disposed on elongated member 116.Elongated member 116 is configured to be navigated through vasculature of the patient, for example, to position electrodes 122 adjacent the target treatment site of the patient. For example, elongated member 116 may be used to access relatively distal vasculature locations in a patient or other relatively distal tissue sites (e.g., relative to a vasculature access point). Example vasculature locations may include, for example, locations in a renal artery, hepatic artery, coronary artery, peripheral vasculature (e.g., carotid, iliac, or femoral artery, or a vein), or cerebral vasculature. In some examples, elongated member 116 is structurally configured to be relatively flexible, pushable, and relatively kink- and buckle- resistant, so that it mayA0013546W001resist buckling when a pushing force is applied to a relatively proximal portion of catheter 112 to advance elongated member 116 distally through vasculature, and so that catheter 112 may resist kinking when traversing around a tight turn in the vasculature.
[0056] Elongated member 116 may have any suitable shape, such as a tubular body or a paddle-like shape. Elongated member 116 may be constructed using any suitable materials. In some examples, elongated member 116 may include one or more polymeric materials, for example, polyamide, polyimide, polyether block amide copolymer sold under the trademark PEBAX, polyethylene terephthalate (PET), polypropylene, aliphatic, polycarbonate-based thermoplastic polyurethane, or a polyether ether ketone (PEEK) polymer that provides elongated member 116 with a predetermined flexibility. The polymeric materials may be extruded as one or more solid or hollow tubes to form elongated member 116.
[0057] In some examples, at least a portion of an outer surface of elongated member 116 may include one or more coatings, such as, but not limited to, an anti-thrombogenic coating, which may help reduce the formation of thrombi in vitro, an anti-microbial coating, and / or a lubricating coating. In some examples, the entire working length of elongated member 116 may be coated with the hydrophilic coating. In other examples, only a portion of the working length of elongated member 116 coated with the hydrophilic coating. This may provide a length of elongated member 116 distal to hub portion 118 with which the clinician may grip elongated member 116, e.g., to rotate elongated member 116 or push elongated member 116 through vasculature. In some examples, the entire working length of elongated member 116 or portions thereof may include a lubricious outer surface, e.g., a lubricious coating. The lubricating coating may be configured to reduce static friction and / or kinetic friction at a surface of elongated member 116 as elongated member 116 is advanced through the vasculature.
[0058] The proximal portion of elongated member 116 may be received within hub portion 118 and can be mechanically connected to hub portion 18 via an adhesive, welding, or another suitable technique or combination of techniques. Hub portion 118 may serve as a handle for catheter 112 allowing the clinician to grasp catheter 112 at hub portion 118 and advance elongated member 116 through vasculature of a patient. In some examples, catheter 112 can include another structure in addition or instead of hub portion 118. For example, catheter 112 or hub portion 118 may include one or more luers or other mechanisms (e.g., access ports) for establishing connections between catheter 112 and other devices.Additionally, or alternatively, catheter 112 may include a strain relief body (not shown),A0013546W001which may be a part of hub portion 118 or may be separate from hub portion 118 to alleviate potential strain of kinking of elongated member 116 near its proximal end.
[0059] In some examples, system 100 includes an electrode 132 (for example, a dispersive electrode or a patient return electrode) electrically connected to generator and sensing device 150 and attached to the exterior of the patient. In some examples, generator and sensing device 150 may be configured to deliver therapy via electrodes 122 and electrode 132 in a monopolar configuration, or by a bipolar or a multipolar configuration of multiple electrodes, or a combination of monopolar and bipolar configuration.
[0060] System 100 may receive impedance feedback of catheter 112. That is, system 100 may receive, such as from catheter 112 and / or electrode 132, signals that system 100 may use to determine the impedance at each of electrodes 122. That is, system 100 may determine, for each of electrodes 122, the impedance in a path from the electrode tip, through the tissue(s) of the patient, to electrode 132. For example, system 100 may, for each of electrodes 122, determine the amount of voltage being applied to the electrode, measure the amount of current flowing from the electrode to electrode 132, and apply Ohm’s law (V = IR) to the voltage and the current to determine the amount of impedance (in Ohms) at the electrode.
[0061] A secondary input 136, for example, a foot pedal, may be connected (e.g., pneumatically connected or electrically connected) to generator and sensing device 150 to allow the clinician to initiate, terminate and, optionally, adjust various operational characteristics of generator and sensing device 150, including, but not limited to, power delivery. System 100 may also include a remote control device (not shown) that can be positioned in a sterile field and operably coupled to one or both of catheter 112 or generator and sensing device 150. The remote control device may be configured to allow for selectively turning on / off electrodes of electrodes 122. In other examples, the remote control device may be built into hub portion 118.
[0062] In some examples, system 100 includes programmer 140, and generator and sensing device 150 may be connected to programmer 140. Generator and sensing device 150 can be configured to receive one or more therapy parameter values with which generator generates and delivers an electrical signal to electrodes 122 via programmer 140. In some examples, the electrical signal comprises a radiofrequency (RF) stimulus configured to ablate tissue at a target treatment site. In some examples, generator and sensing device 150 or programmer 140 may include one or more evaluation or feedback modules to provide feedback to the clinician before, during, and / or after therapy.A0013546W001
[0063] Programmer 140 and generator and sensing device 150 may form computing system 120. Programmer 140 may include user interface 148, processing circuitry 142, user interface 148, and memory 144. In some examples, processing circuitry 142 and memory 144 may perform functions described with respect to processing circuitry 152 and memory 154 of generator and sensing device 150.
[0064] A user, either a clinician or patient, may interact with processing circuitry 142 through user interface 148. User interface 148 may include a display, such as a liquid crystal display (LCD), light-emitting diode (LED) display, or other screen, to present information related to stimulation therapy, and buttons or a pad to provide input to programmer 140. In examples in which user interface 148 requires a 3D environment, the user interface may support 3D environments such as a holographic display, a stereoscopic display, an autostereoscopic display, a head-mounted 3D display, or any other display that is capable of presenting a 3D image to the user. Buttons of user interface 148 may include an on / off switch, plus and minus buttons to zoom in or out or navigate through options, a select button to pick or store an input, and pointing device, e.g. a mouse, trackball, or stylus. Other input devices may be a wheel to scroll through options or a touch pad to move a pointing device on the display. In some examples, the display may be a touch screen that enables the user to select options directly from the display screen.
[0065] Memory 144 includes computer-readable instructions that, when executed by processing circuitry 142, causes programmer 140 to perform various functions. Processing circuitry 142 may include any one or more microprocessors, controllers, digital signal processors (DSPs), application specific integrated circuits (ASICs), field-programmable gate arrays (FPGAs), or equivalent discrete or integrated digital or analog logic circuitry, and the functions attributed to processing circuitry 142 herein may be embodied as software, firmware, hardware or any combination thereof.
[0066] Memory 144 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital media. Memory 144 may store any suitable information for determining apposition information associated with catheter 112. Memory 144 may also store operating instructions with which processing circuitry 142 controls the operation of programmer 140.
[0067] Memory 144 may store program instructions, such as neural network algorithms. The program instructions may include one or more program modules that are executable by processing circuitry 142. For example, memory 144 may store catheter location model 124,A0013546W001which may be a model trained via machine learning to determine the location of catheter 112 in the patient. When executed by processing circuitry 142, such program instructions, such as program instructions of catheter location model 124, may cause processing circuitry 142 to provide the functionality ascribed to it herein. The program instructions may be embodied in software, firmware, and / or RAMware.
[0068] In accordance with aspects of this disclosure, computing system 120 may receive temperature feedback and / or impedance feedback associated with electrodes 122 of catheter 112, and may use the temperature feedback and / or the impedance feedback to determine whether catheter 112 is located in a renal artery or in a hepatic artery of a patient. Computing system 120 may, based on determining whether catheter 112 is located in a renal artery or in a hepatic artery of the patient, select a treatment algorithms for performing therapeutic ablation of the tissues of the artery in which catheter 112 is located. That is, if computing system 120 detects that catheter 112 is in a renal artery, computing system 120 may select a renal treatment algorithm for electrodes 122 to perform therapeutic ablation to treat the renal artery of the patient according to the renal treatment algorithm. If computing system 120 detects that catheter 112 is in a hepatic artery, computing system 120 may select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation to treat the hepatic artery of the patient according to the hepatic treatment algorithm.
[0069] Temperature feedback may be temperatures measured at each of electrodes 122. Processing circuitry 152 of generator and sensing device 150 and / or processing circuitry 142 of programmer 140 may be configured to receive temperature feedback (e.g., from catheter 112) indicative of the temperatures measured at each of electrodes, such as every 5 milliseconds (ms), every 10ms, every 20 ms, and the like.
[0070] Impedance feedback may be the impedances measured at each of electrodes 122 (e.g., the impedances between each of electrodes 122 and electrode 132). Processing circuitry 152 of generator and sensing device 150 and / or processing circuitry 142 of programmer 140 may be configured to receive impedance feedback, such as the amounts of voltage applied to electrodes 122 and the amounts of current flowing from each of electrodes to electrode 132 that processing circuitry 152 and / or processing circuitry 142 may use to calculate impedances at each of electrodes 122 (e.g.,. using Ohm’s law), such as every 10ms, every 50 ms, every 100ms, and the like.
[0071] Processing circuitry 152 and / or processing circuitry 142 may use any suitable technique to determine, based on temperature feedback and / or impedance feedback from catheter 112, whether catheter 112 is located in a renal artery or a hepatic artery. That is,A0013546W001processing circuitry 152 and / or 142 may determine the location of electrodes 122 as being in one of a renal artery of the patient or a hepatic artery of the patient. In some examples, processing circuitry 152 and / or processing circuitry 142 may execute catheter location model 124 to determine, based on temperature feedback and / or impedance feedback associated with catheter 112, whether catheter 112 is located in a renal artery or a hepatic artery. Catheter location model 124 stored in memory 144 and / or memory 154 is a neural network algorithm trained via machine learning to take a plurality of signals, including temperature feedback and / or impedance feedback associated with electrodes 122 of catheter 112 as inputs to determine the location of catheter 112 in the patient. That is, catheter location model 124 may include a deep learning architecture such as a recurrent neural network, convolutional neural network, and the like that includes multiple layers to progressively extract higher level features from inputs to catheter location model 124.
[0072] A neural network algorithm, or artificial neural network, may include a trainable or adaptive algorithm utilizing nodes that define rules. For example, a respective node of a plurality of nodes may utilize a function, such as a non-linear function or if-then rules, to generate an output based on an input. A respective node of the plurality of nodes may be connected to one or more different nodes of the plurality of nodes along an edge, such that the output of the respective node includes the input of the different node. The functions may include parameters that may be determined or adjusted using a training set of inputs and desired outputs, such as, for example, a predetermined association between a plurality of signals or values, such as temperature information and / or impedance information, along with a learning rule, such as a back-propagation learning rule. The back-propagation learning rule may utilize one or more error measurement comparing the desired output to the output produced by the neural network algorithm to train the neural network algorithm by varying the parameters to minimize the one or more error measurements.
[0073] An example neural network includes a plurality of nodes, at least some of the nodes having node parameters. An input including at least temperature information derived from temperature feedback from electrodes 122 of catheter 112 or impedance information derived from impedance feedback from electrodes 122 of catheter 112 and / or electrode 132 may be provided (input) to a first node of the neural network algorithm. In some examples, the input may include a plurality of inputs, each input into a respective node. The first node may include a function configured to determine an output based on the input and one or more adjustable node parameters. In some examples, the neural network may include a propagation function configured to determine an input to a subsequent node based on the output of aA0013546W001preceding node and a bias value. In some examples, a learning rule may be configured to modify one or more node parameters to produce a favored output. For example, the favored output may be constrained by one or more threshold values and / or to minimize one or more error measurements. The favored output may include an output of a single node, a set of nodes, or the plurality of nodes.
[0074] The neural network algorithm may iteratively modify the node parameters until the output includes the favored output. In this way, processing circuitry 110 may be configured to iteratively evaluating outputs of the neural network algorithm and iteratively modifying at least one of the node parameters based on the evaluation of the outputs of the neural network algorithm to determine whether catheter 112 is located in a renal artery or a hepatic artery of a patient, based on the modified neural network algorithm.
[0075] For example, catheter location model 124 may output a probability distribution that includes a probability that catheter 112 is located in a renal artery and a probability that catheter 112 is located in a hepatic artery. Processing circuitry 152 and / or processing circuitry 142 may determine, based on the output of catheter location model 124, whether catheter 112 is located in a hepatic artery or renal artery. For example, if processing circuitry 152 and / or processing circuitry 142 determines that the probability of catheter 112 being in the renal artery is higher than the probability of catheter 112 being in the hepatic artery, processing circuitry 152 and / or processing circuitry 142 may determine that catheter 112 is in the renal artery. Similarly, if processing circuitry 152 and / or processing circuitry 142 determines that the probability of catheter 112 being in the hepatic artery is higher than the probability of catheter 112 being in the renal artery, processing circuitry 152 and / or processing circuitry 142 may determine that catheter 112 is in the hepatic artery.
[0076] Processing circuitry 152 and / or processing circuitry 142 may, based on the location of catheter 112, select a treatment algorithm for performing ablation in the determined location within the body of the patient. A treatment algorithm may control the delivery of RF energy by electrodes 122, such as the power of the energy delivered by each of electrodes 122, the temperature of each of electrodes 122, the patterns of energy delivery of each of electrodes 122, the duration of energy delivery by each of electrodes 122, and the like. Such parameters of a treatment algorithm for ablating tissues of a renal artery (referred to herein as a renal algorithm) may differ from the parameters of a treatment algorithm for ablating tissues of a hepatic artery (referred to herein as a hepatic algorithm).
[0077] Processing circuitry 152 and / or processing circuitry 142 may, based on the determined location of catheter 112 being in a renal artery, select a treatment algorithm forA0013546W001ablating tissues of a renal artery. Similarly, processing circuitry 152 and / or processing circuitry 142 may, based on the determined location of catheter 112 being in a hepatic artery, select a hepatic algorithm for ablating tissues of a hepatic artery.
[0078] Processing circuitry 152 may be configured to communicate with drive circuitry 158 to electrically drive electrodes 122 of catheter 112 to transmit energy, such as in the form of electrical energy, RF energy, etc. according to the selected treatment algorithm. That is, drive circuitry 158 may drive each of electrodes 122 to perform ablation of the tissues to which electrodes 122 is apposed according to the selected treatment algorithm.
[0079] In some examples, to determine the location of catheter 112, processing circuitry 152 may be configured to communicate with drive circuitry 158 to electrically drive electrodes 122 to deliver an energy pulse (e.g., a RF pulse) to tissues to which electrodes 122 are apposed. The energy pulse may be relatively low-powered, such as up to 5 watts of power, and may be of a short duration in the order of seconds, such as approximately 1 second or less than 2 seconds. In some examples, the energy pulse may start at 2 watts of power and may step up to 3 watts of power.
[0080] Processing circuitry 152 and / or processing circuitry 142 may be configured to receive temperature feedback measured during and / or after delivery of the energy pulse from catheter 112. The temperature feedback may include the temperatures measured at each of electrodes 122 during and after delivery of the energy pulse. Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the temperature feedback received during and / or after delivery of the energy pulse, temperature information associated with the energy pulse, such as a rate of temperature change (e.g., increase or decrease) from during delivery of energy pulse to after delivery of the energy pulse for each of electrodes 122, a magnitude of temperature change from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, an average temperature from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, and the like.
[0081] Processing circuitry 152 and / or processing circuitry 142 may also be configured to receive impedance feedback measured during and / or after delivery of the energy pulse from catheter 112. The impedance feedback may include the impedances measured at each of electrodes 122 during and after delivery of the energy pulse. Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the impedance feedback received during and / or after delivery of the energy pulse, impedance information associatedA0013546W001with the energy pulse, such as changes in impedance of each of electrodes 122 from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122.
[0082] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the temperature information associated with the energy pulse and / or the impedance information associated with the energy pulse, as determined from the temperature feedback and / or impedance feedback measured during and / or after delivery of the energy pulse, whether catheter 112 is located in a renal artery or in a hepatic artery of a patient. For example, processing circuitry 152 and / or processing circuitry 142 may input the temperature information associated with the energy pulse and / or the impedance information associated with the energy pulse into catheter location model 124. Catheter location model 124 may be trained to use inputs, such as temperature information associated with the energy pulse and / or the impedance information associated with the energy pulse, as determined from the temperature feedback and / or impedance feedback measured during and / or after delivery of the energy pulse, to determine, based on the inputs, whether catheter 112 is located within a renal artery or a hepatic artery of the patient. Catheter location model 124 may therefore, based on the temperature information associated with the energy pulse and / or the impedance information associated with the energy pulse, output an indication of whether catheter 112 is located in a renal artery or in a hepatic artery of a patient.
[0083] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the temperature information associated with the energy pulse with a renal ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a renal ablation threshold may be a range of values for one or more of the rate of temperature increase or decrease from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, the magnitude of temperature change from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, and / or the average temperature from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, within which may be indicative of catheter 112 being located within the renal artery of the patient.
[0084] If processing circuitry 152 and / or processing circuitry 142 determines that the temperature information associated with the energy pulse is within a renal ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a renal artery of the patient. Processing circuitry 152 may, in response to determining that catheter 112 is located in a renal artery of the patient, select a renal treatment algorithm for catheter 112 to perform therapeutic ablation in the renal artery of the patient.A0013546W001
[0085] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the temperature information associated with the energy pulse with a hepatic ablation threshold to determine whether catheter 112 is located within a hepatic artery. For example, a hepatic ablation threshold may be a range of values for one or more of the rate of temperature increase or decrease from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, the magnitude of temperature change from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, and / or the average temperature from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, within which may be indicative of catheter 112 being located within the hepatic artery of the patient.
[0086] If processing circuitry 152 and / or processing circuitry 142 determines that the temperature information associated with the energy pulse is within a hepatic ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a hepatic artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a hepatic artery of the patient, select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation in the hepatic artery of the patient.
[0087] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the impedance information associated with the energy pulse with a renal ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a renal ablation threshold may be a range of values for changes in impedance of each of electrodes 122 from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122. within which may be indicative of catheter 112 being located within the renal artery of the patient.
[0088] If processing circuitry 152 and / or processing circuitry 142 determines that the impedance information associated with the energy pulse is within a renal ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a renal artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a renal artery of the patient, select a renal treatment algorithm for catheter 112 to perform therapeutic ablation in the renal artery of the patient.
[0089] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the impedance information associated with the energy pulse with a hepatic ablation threshold to determine whether catheter 112 is located within a renal artery. For example, aA0013546W001hepatic ablation threshold may be a range of values for changes in impedance of each of electrodes 122 from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122. within which may be indicative of catheter 112 being located within the hepatic artery of the patient.
[0090] If processing circuitry 152 and / or processing circuitry 142 determines that the impedance information associated with the energy pulse is within a hepatic ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a hepatic artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a hepatic artery of the patient, select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation in the hepatic artery of the patient.
[0091] In some examples, system 100 may use catheter 112 to deliver energy pulses as catheter 112 performs therapeutic ablation to tissues of a vessel to check the apposition of electrodes 122 to the tissues. Processing circuitry 152 may be configured to communicate with drive circuitry 158 to electrically drive electrodes 122 to deliver an energy pulse to tissues to which electrodes 122 are apposed as catheter 112 performs therapeutic ablation to the tissues. Processing circuitry 152 may cause electrodes 122 to periodically deliver an energy pulse to the tissues as catheter 112 performs the therapeutic ablation to the tissues, such as every 15 seconds during a 60-second therapeutic ablation procedure.
[0092] The energy pulse may be similar to the energy pulse described above. The energy pulse relatively low-powered, such as up to 5 watts of power, and may be of a short duration in the order of seconds, such as approximately 1 second or less than 2 seconds. In some examples, the energy pulse may start at 2 watts of power and may step up to 3 watts of power.
[0093] Processing circuitry 152 and / or processing circuitry 142 may be configured to receive temperature feedback measured during and / or after delivery of each of the energy pulse from catheter 112. The temperature feedback may include the temperatures measured at each of electrodes 122 during and after delivery of each energy pulse. Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the temperature feedback received during and / or after delivery of each energy pulse, temperature information associated with each energy pulse, such as a rate of temperature decrease from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, a magnitude of temperature decrease from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, an average temperature from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, and the like.A0013546W001
[0094] Processing circuitry 152 and / or processing circuitry 142 may be configured to determine, based on the temperature feedback measured during and / or after delivery of each of the energy pulse from catheter 112, how well-apposed electrodes 122 are to tissues of a vessel. If an electrode is not well-apposed, the electrode may experience a faster rate of temperature decrease than a well-apposed electrode.
[0095] In some examples, catheter location model 124 may be trained to determine, based on temperature information, such as rates of temperature decrease of electrodes 122 from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, whether electrodes 122 are well-apposed to tissues of a vessel. Thus, after each energy pulse, processing circuitry 152 and / or processing circuitry 142 may input the rates of temperature decrease of electrodes 122 from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122 into catheter location model 124, and catheter location model 124 may, based on the inputted temperature information, output an indication of whether electrodes 122 are well-apposed to tissues of a vessel.
[0096] Processing circuitry 152 and / or processing circuitry 142 may, based on whether electrodes 122 are well-apposed to tissues of a vessel, adjust the treatment algorithm that controls energy delivery by electrodes 122 to the tissues of the vessel. For example, if processing circuitry 152 and / or processing circuitry 142 determines that one or more of electrodes 122 are not well-apposed to tissues of a vessel, processing circuitry 152 and / or processing circuitry 142 may adjust the treatment algorithm to increase the power of the energy delivery by the one or more electrodes 122 to the tissues of the vessel.
[0097] In some examples, processing circuitry 152 and / or processing circuitry 142 may be configured to receive temperature feedback and / or impedance feedback associated with electrodes 122 that are measured during an initial ramp of energy delivery (e.g., RF delivery) by catheter 112 to perform therapeutic ablation. Processing circuitry 152 and / or processing circuitry 142 may be configured to determine, based on the temperature feedback and / or impedance feedback during the initial ramp of energy delivery, whether catheter 112 is located in a renal artery or in a hepatic artery of a patient. An initial ramp of energy delivery may be a time, at the start of therapeutic ablation, during which generator and sensing device 150 ramps up (i.e., gradually increases) the power of energy (e.g., RF energy) delivered by electrodes 122 of catheter 112 to perform therapeutic ablation of tissues. Such a ramp up of power may help minimize tissue damage and may optimize lesion formation by gradually increasing the temperature at the target tissue. In some examples, the initial ramp of energyA0013546W001delivery may be the first 10 seconds of energy delivery, the first 15 seconds of energy delivery, and the like.
[0098] Processing circuitry 152 and / or processing circuitry 142 may be configured to receive temperature feedback associated with electrodes 122 and measured during and the initial ramp of energy delivery by catheter 112. Such temperature feedback may include temperature measurements at each of electrodes 122 during the initial ramp of energy delivery. Processing circuitry 152 and / or processing circuitry 142 may be configured to determine, based on the temperature feedback received during the initial ramp of RF delivery, temperature information associated with the energy delivery, such as the average temperature of each of electrodes 122 during the initial ramp, the magnitude of temperature increase of each of electrodes 122 during the initial ramp, the rate of temperature increase of each of electrodes 122 during the initial ramp, variations in temperature increases between electrodes 122 during the initial ramp, and the like.
[0099] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the temperature information associated with electrodes 122, as determined from the temperature feedback associated with electrodes 122 and measured during and the initial ramp of energy delivery by catheter 112, whether catheter 112 is located in a renal artery or in a hepatic artery of a patient. For example, processing circuitry 152 and / or processing circuitry 142 may input the temperature information associated with electrodes 122 and measured during and the initial ramp of energy delivery by catheter 112 into catheter location model 124. Catheter location model 124 may be trained to use inputs, such as temperature information associated with electrodes 122 and measured during and the initial ramp of energy delivery by catheter 112, to determine, based on the inputs, whether catheter 112 is located within a renal artery or a hepatic artery of the patient. Catheter location model 124 may therefore, based on the inputted temperature information, output an indication of whether catheter 112 is located in a renal artery or in a hepatic artery of a patient.
[0100] In some examples, processing circuitry 152 and / or processing circuitry 142 may also be configured to receive impedance feedback measured during and the initial ramp of RF delivery by catheter 112. The impedance feedback may include the impedances measured at each of electrodes 122 during the initial ramp of energy delivery (e.g., RF delivery).Processing circuitry 152 and / or processing circuitry 142 may be configured to determine, based on the impedance feedback received during the initial ramp of energy delivery, impedance information associated with the energy delivery, such as the average impedance drop of each of electrodes 122 during the initial ramp, the magnitude of the impedance dropA0013546W001of each of electrodes 122 during the initial ramp, the rate of impedance drop of each of electrodes 122 during the initial ramp, variations in impedance drops between electrodes 122 during the initial ramp, and the like.
[0101] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the temperature information associated with electrodes 122, as determined from the temperature feedback associated with electrodes 122 and measured during and the initial ramp of energy delivery by catheter 112, as well as impedance information associated with electrodes 122, as determined from the impedance feedback associated with electrodes 122 and measured during and the initial ramp of energy delivery by catheter 112, whether catheter 112 is located in a renal artery or in a hepatic artery of a patient. For example, processing circuitry 152 and / or processing circuitry 142 may input the temperature information and impedance information associated with electrodes 122 and measured during and the initial ramp of energy delivery by catheter 112 into catheter location model 124. Catheter location model 124 may be trained to use inputs, such as temperature information and impedance information associated with electrodes 122 and measured during and the initial ramp of energy delivery by catheter 112, to determine, based on the inputs, whether catheter 112 is located within a renal artery or a hepatic artery of the patient. Catheter location model 124 may therefore, based on the inputted temperature information and impedance information, output an indication of whether catheter 112 is located in a renal artery or in a hepatic artery of a patient.
[0102] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the temperature information measure during the initial ramp of energy delivery with a renal ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a renal ablation threshold may be a range of values for one or more of the average temperature of each of electrodes 122 during the initial ramp, the magnitude of temperature increase of each of electrodes 122 during the initial ramp, the rate of temperature increase of each of electrodes 122 during the initial ramp, variations in temperature increases between electrodes 122 during the initial ramp, and the like, within which may be indicative of catheter 112 being located within the renal artery of the patient.
[0103] If processing circuitry 152 and / or processing circuitry 142 determines that the temperature information measured during the initial ramp of energy delivery is within a renal ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a renal artery of the patient. Processing circuitry 152 may, in response toA0013546W001determining that catheter 112 is located in a renal artery of the patient, select a renal treatment algorithm for catheter 112 to perform therapeutic ablation in the renal artery of the patient.
[0104] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the temperature information measured during the initial ramp of energy delivery with a hepatic ablation threshold to determine whether catheter 112 is located within a hepatic artery. For example, a hepatic ablation threshold may be a range of values for one or more of the average temperature of each of electrodes 122 during the initial ramp, the magnitude of temperature increase of each of electrodes 122 during the initial ramp, the rate of temperature increase of each of electrodes 122 during the initial ramp, variations in temperature increases between electrodes 122 during the initial ramp, and the like, within which may be indicative of catheter 112 being located within the hepatic artery of the patient.
[0105] If processing circuitry 152 and / or processing circuitry 142 determines that the temperature information measured during the initial ramp of energy delivery is within a hepatic ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a hepatic artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a hepatic artery of the patient, select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation in the hepatic artery of the patient.
[0106] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the impedance information measured during the initial ramp of energy delivery with a renal ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a renal ablation threshold may be a range of values for one or more of the average impedance drop of each of electrodes 122 during the initial ramp, the magnitude of the impedance drop of each of electrodes 122 during the initial ramp, the rate of impedance drop of each of electrodes 122 during the initial ramp, variations in impedance drops between electrodes 122 during the initial ramp, and the like, within which may be indicative of catheter 112 being located within the renal artery of the patient.
[0107] If processing circuitry 152 and / or processing circuitry 142 determines that the impedance information measured during the initial ramp of energy delivery is within a renal ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a renal artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a renal artery of the patient, select a renal treatment algorithm for catheter 112 to perform therapeutic ablation in the renal artery of the patient.A0013546W001
[0108] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the impedance information measured during the initial ramp of energy delivery with a hepatic ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a hepatic ablation threshold may be a range of values for one or more of the average impedance drop of each of electrodes 122 during the initial ramp, the magnitude of the impedance drop of each of electrodes 122 during the initial ramp, the rate of impedance drop of each of electrodes 122 during the initial ramp, variations in impedance drops between electrodes 122 during the initial ramp, and the like, within which may be indicative of catheter 112 being located within the hepatic artery of the patient.
[0109] If processing circuitry 152 and / or processing circuitry 142 determines that the impedance information measured during the initial ramp of energy delivery is within a hepatic ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a hepatic artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a hepatic artery of the patient, select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation in the hepatic artery of the patient.
[0110] In some examples, processing circuitry 152 and / or processing circuitry 142 may be configured to receive impedance feedback at each electrodes 122 measured during a time period immediately prior to the start of energy delivery (e.g., RF delivery) by catheter 112 to perform therapeutic ablation. Processing circuitry 152 and / or processing circuitry 142 may measure impedance feedback, such as the measured impedance, of each of electrodes 122 for a period of time immediately prior to start of RF delivery by catheter 112, such as the preceding 10 seconds, preceding 20 seconds, and the like prior to the start of RF ablation.
[0111] Impedance feedback may differ between renal arteries and hepatic arteries in patients. For example, impedance data may be used to detect physiological parameters, such as flow rates, breathing motion, heart rate, etc. that may differ between renal arteries and hepatic arteries in patients. As such, processing circuitry 152 and / or processing circuitry 142 may be able to determine, based on the impedance feedback prior to energy delivery, whether catheter 112 is located in a renal artery or in a hepatic artery of a patient.
[0112] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the impedance feedback at each electrodes 122 measured during a time period immediately prior to the start of energy delivery, whether catheter 112 is located in a renal artery or in a hepatic artery of a patient. For example, processing circuitry 152 and / or processing circuitry 142 may input the impedance feedback, such as the measured impedancesA0013546W001of each of electrodes 122, into catheter location model 124. Catheter location model 124 may be trained to use inputs, such as the impedance feedback at electrodes 122 measured during a time period immediately prior to the start of energy delivery, to determine, based on the inputs, whether catheter 112 is located within a renal artery or a hepatic artery of the patient. Catheter location model 124 may therefore, based on the inputted impedance information, output an indication of whether catheter 112 is located in a renal artery or in a hepatic artery of a patient.
[0113] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the impedance information measured during the time period immediately prior to energy delivery with a renal ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a renal ablation threshold may be a range of values for the impedance values within which may be indicative of catheter 112 being located within the renal artery of the patient.
[0114] If processing circuitry 152 and / or processing circuitry 142 determines that the impedance information is within a renal ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a renal artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a renal artery of the patient, select a renal treatment algorithm for catheter 112 to perform therapeutic ablation in the renal artery of the patient.
[0115] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the impedance information measured during the time period immediately prior to energy delivery with a hepatic ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a hepatic ablation threshold may be a range of impedance values within which may be indicative of catheter 112 being located within the hepatic artery of the patient.
[0116] If processing circuitry 152 and / or processing circuitry 142 determines that the impedance information is within a hepatic ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a hepatic artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a hepatic artery of the patient, select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation in the hepatic artery of the patient.
[0117] In some examples, electrode 132 may include two return electrode monitoring (REM) pads placed at different locations on a patient’s body, and generator and sensing device 150 may connect to both REM pads. For example, a first REM pad may be placed onA0013546W001the left side of the lower back of a patient, and a second REM pad may be placed on the left side or the right side of the mid back of the patient.
[0118] REM pads placed at different locations on a patient may create different pathways for current flow from electrodes 122. As such, due to differences in anatomical locations between renal and hepatic arteries, having multiple REM pads placed at different locations on a patient may elicit differences in measured impedances of electrodes 122 that can be used by system 100 to determine the location of catheter 112.
[0119] Processing circuitry 152 and / or processing circuitry 142 may be configured to receive impedance feedback at each of electrodes 122 measured prior to the start of RF delivery by catheter 112. The impedance feedback at each of electrodes 122 may include, for each electrode of electrodes 122, the impedance between the electrode and the first of the two REM pads placed on the patient, referred to herein as a first impedance, and the impedance between the electrode and the second of the two REM pads placed on the patient, referred to herein as a second impedance. Processing circuitry 152 and / or processing circuitry 142 may, for each of electrodes 122, measure the first impedance and the second impedance simultaneously, or may, for each of electrodes 122, alternate between measuring the first impedance and the second impedance.
[0120] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the impedance feedback at each electrodes 122 measured during a time period immediately prior to the start of energy delivery, whether catheter 112 is located in a renal artery or in a hepatic artery of a patient. For example, processing circuitry 152 and / or processing circuitry 142 may input the impedance feedback, such as the measured first and second impedances of each of electrodes 122, into catheter location model 124. Catheter location model 124 may be trained to use inputs, such as the impedance feedback at electrodes 122 measured during a time period immediately prior to the start of energy delivery, to determine, based on the inputs, whether catheter 112 is located within a renal artery or a hepatic artery of the patient. Catheter location model 124 may therefore, based on the inputted impedance information, output an indication of whether catheter 112 is located in a renal artery or in a hepatic artery of a patient.
[0121] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the first and second impedances measured during the time period immediately prior to energy delivery with a renal ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a renal ablation threshold may be a range of impedanceA0013546W001values within which may be indicative of catheter 112 being located within the renal artery of the patient.
[0122] If processing circuitry 152 and / or processing circuitry 142 determines that the first and second impedances are within a renal ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a renal artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a renal artery of the patient, select a renal treatment algorithm for catheter 112 to perform therapeutic ablation in the renal artery of the patient.
[0123] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the first and second impedances measured during the time period immediately prior to energy delivery with a hepatic ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a hepatic ablation threshold may be a range of impedance values within which may be indicative of catheter 112 being located within the hepatic artery of the patient.
[0124] If processing circuitry 152 and / or processing circuitry 142 determines that the first and second impedances are within a hepatic ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a hepatic artery of the patient.Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a hepatic artery of the patient, select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation in the hepatic artery of the patient.
[0125] In some examples, processing circuitry 152 and / or processing circuitry 142 may be configured to receive impedance feedback that includes bipolar impedance values of electrodes 122, measured during a time period immediately prior to the start of energy delivery (e.g., RF delivery) by catheter 112 to perform therapeutic ablation of tissues. The impedance feedback may include bipolar impedance values of pairs of electrodes 122 in place of or along with monopolar impedance values of electrodes 122 measured prior to the start of RF delivery by catheter 112.
[0126] As discussed above, impedance feedback may differ between renal arteries and hepatic arteries in patients. Bipolar impedance values of electrodes 122 may be more localized compared to monopolar impedance values of electrodes 122, and may therefore contain more specific information related to the structures directly surrounding the renal or hepatic arteries.
[0127] A bipolar impedance value may be the impedance between a pair of electrodes of electrodes 122 that contact the tissue of a vessel within the patient, and may be a measure ofA0013546W001the resistance of between the two electrodes through the tissue of the vessel. Generator and sensing device 150 may send a known current (e.g., a 1 milliamp current) through a first electrode of the pair of electrodes, and the current may travel from the first electrode, through the tissue of the vessel, to the second electrode of the pair of electrodes. Processing circuitry 152 and / or processing circuitry 142 may measure the voltage drop between the two electrodes, and may use Ohm’s law (e.g., R = V / I) to determine the bipolar impedance value for the pair of electrodes.
[0128] In some examples, generator and sensing device 150 may cause catheter 112 to perform a cyclical low-power (e.g., approximately 1 watt of power) frequency sweep during measurement of bipolar impedance values between pairs of electrodes of electrodes 122 of catheter 112 during a time period immediately prior to the start of energy delivery by catheter 112 to perform therapeutic ablation. Impedance of materials, including fat, perivascular tissue, blood, etc. may change with respect to the frequency of the electrical signal conducted through the materials. By sweeping a range of frequencies, the resulting electrical impedance spectrogram may contain information about the structures surrounding the artery in which catheter 112 is placed, and may also contain information regarding the hemodynamics within the vessel. Given the anatomical differences and the hemodynamic (e.g., flow rate) differences between the renal and hepatic arteries, the electrical impedance spectrogram can be used as a “fingerprint” to identify the artery in which catheter 112 is placed.
[0129] The frequencies during this sweep will range from low frequency to high frequency as different frequencies may have better sensitivities for detecting biological components between renal and hepatic arteries. Generator and sensing device 150 may cycle the current that is sent to an electrode of a pair of electrodes through a range of frequencies, such as between 1 kilohertz (kHz) and 100 kHz, in order for system 100 to measure bipolar impedance between the pair of electrodes of electrodes 122. For example, generator and sensing device 150 may cycle the current from 2 kHz, to 4 kHz, to 8 kHz, to 16 kHz, to 32 kHz, to 64 kHz, to 32 kHz, to 16 kHz, to 8 kHz, to 4 kHz, to 2 kHz, and so on. At each frequency, processing circuitry 152 and / or processing circuitry 142 may measure the voltage drop between the pair electrodes, and may use Ohm’s law (e.g., R = V / I) to determine the bipolar impedance value for the pair of electrodes.
[0130] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the bipolar impedance values of pairs of electrodes of electrodes 122, measured during a time period immediately prior to the start of energy delivery, whether catheter 112 is located in a renal artery or in a hepatic artery of a patient. For example,A0013546W001processing circuitry 152 and / or processing circuitry 142 may input the bipolar impedance values of pairs of electrodes of electrodes 122, measured during a time period immediately prior to the start of energy delivery, into catheter location model 124. Catheter location model 124 may be trained to use inputs, such as the bipolar impedance values of pairs of electrodes of electrodes 122, measured during a time period immediately prior to the start of energy delivery, to determine, based on the inputs, whether catheter 112 is located within a renal artery or a hepatic artery of the patient. Catheter location model 124 may therefore, based on the inputted impedance information, output an indication of whether catheter 112 is located in a renal artery or in a hepatic artery of a patient.
[0131] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the bipolar impedance values of pairs of electrodes of electrodes 122, measured during a time period immediately prior to the start of energy delivery with a renal ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a renal ablation threshold may be a range of impedance values within which may be indicative of catheter 112 being located within the renal artery of the patient.
[0132] If processing circuitry 152 and / or processing circuitry 142 determines that the bipolar impedance values of pairs of electrodes of electrodes 122, measured during a time period immediately prior to the start of energy delivery are within a renal ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a renal artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in a renal artery of the patient, select a renal treatment algorithm for catheter 112 to perform therapeutic ablation in the renal artery of the patient.
[0133] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the bipolar impedance values of pairs of electrodes of electrodes 122, measured during a time period immediately prior to the start of energy delivery with a hepatic ablation threshold to determine whether catheter 112 is located within a renal artery. For example, a hepatic ablation threshold may be a range of impedance values within which may be indicative of catheter 112 being located within the hepatic artery of the patient.
[0134] If processing circuitry 152 and / or processing circuitry 142 determines that the bipolar impedance values of pairs of electrodes of electrodes 122, measured during a time period immediately prior to the start of energy delivery are within a hepatic ablation threshold, processing circuitry 152 and / or 142 may determine that catheter 112 is located in a hepatic artery of the patient. Processing circuitry 152 and / or processing circuitry 142 may, inA0013546W001response to determining that catheter 112 is located in a hepatic artery of the patient, select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation in the hepatic artery of the patient.
[0135] In some examples, to accurately account for patient-to-patient variations, computing system 120 is configured to perform an active pre-treatment calibration phase prior to delivering therapeutic ablation. Computing system 120 may perform such a calibration phase during the same clinical visit (e.g., the same day) during which the patient receives treatment via system 100.
[0136] During this pre-treatment calibration phase, processing circuitry 142 and / or processing circuitry 152 may determine patient-specific baseline impedance profiles for a patient associated with catheter 112 being positioned in different anatomical positions within the patient. For example, processing circuitry 142 and / or processing circuitry 152 may measure one or more impedance values associated with catheter 112 being positioned in a first anatomical position, such as within a renal artery, to determine a first patient-specific baseline impedance profile, and may measure one or more impedance values associated with catheter 112 being positioned in a second anatomical position, such as within a hepatic artery, to determine a second patient-specific baseline impedance profile.
[0137] The differences detected between the first patient-specific baseline impedance profile and the second patient-specific baseline impedance profile may be attributable to distinct global physiological features associated with each respective anatomical location. For example, when electrodes 122 of catheter 112 measure impedance within a vessel, the resulting impedance signals may be heavily influenced by local blood flow dynamics, including the magnitude and pulsatility of the blood flow, which may naturally differ between the renal artery and the hepatic artery. Furthermore, the impedance measurements may be affected by the specific tissue structures surrounding the respective arteries and the relative transmission distance from electrodes 122 to electrode 132. By capturing these inherent variations in hemodynamics, surrounding anatomical structures, and return path distances during the pre-treatment calibration phase, processing circuitry 142 and / or processing circuitry 152 can establish a highly accurate, patient-specific baseline signature for each target vessel.
[0138] The impedance values for catheter 112 being positioned in different anatomical positions may include and / or indicate, for each anatomical position in which catheter 112 is positioned, bipolar impedance between two or more of electrodes 122 and / or impedance (e.g., monopolar impedance) between an electrode of electrodes 122 of catheter 112 and two orA0013546W001more REM pads placed at different anatomical locations on the body of the patient. During the pre-treatment calibration phase or the therapeutic ablation procedure, processing circuitry 142 and / or processing circuitry 152 may independently measure a first monopolar impedance between at least one of electrodes 122 of catheter 112 and the first return electrode monitoring pad, and a second monopolar impedance between the at least one of electrodes 122 and the second return electrode monitoring pad.
[0139] Measuring impedance values between at least one of electrodes 122 and multiple REM pads may allow computing system 120 to establish a multi-dimensional spatial impedance profile for a target tissue site. Because a first return electrode monitoring pad and a second return electrode monitoring pad may be situated at different anatomical locations, the electrical current traveling from one of electrodes 122 to each respective REM pad may traverse different anatomical structures and pathways. While the first monopolar impedance measured between the renal artery and the first return electrode monitoring pad might be similar to the first monopolar impedance measured between the hepatic artery and the first return electrode monitoring pad, the second monopolar impedance measured to the second return electrode monitoring pad may differ significantly between the two arterial locations. By collecting and comparing these separate impedance values for different REM pads, processing circuitry 142 and / or processing circuitry 152 may create a highly specific spatial fingerprint to more accurately differentiate whether catheter 112 is located within the renal artery or the hepatic artery.
[0140] In order to ensure the accuracy of the patient-specific baseline impedance profiles, computing system 120 may ensure that one or more external procedural variables remain static during the pre-treatment calibration phase. For example, electrode 132, which may include one or more REM pads attached to the exterior of the patient, may establish a return path for the impedance measurements. To maintain a consistent reference, electrode 132 may not be moved or repositioned on the body of the patient between the measurement of the first patient-specific baseline impedance profile and the measurement of the second patientspecific baseline impedance profile. Maintaining static external variables may ensure that any measured differences between the baselines accurately reflect true physiological variations between the anatomical locations, such as distinct blood flow dynamics, distances to electrode 132, and surrounding anatomical structures of the renal artery compared to the hepatic artery, rather than measurement artifacts introduced by altering the position of electrode 132.Computing system 120 may subsequently use the stored first and second patient-specificA0013546W001baseline impedance profiles to accurately identify the location of catheter 112 and select the appropriate treatment algorithm during the therapeutic ablation procedure.
[0141] In some examples, generator and sensing device 150 may cause catheter 112 to perform a cyclical low-power (e.g., approximately 1 watt of power) frequency sweep during measurement of the impedance values. Generator and sensing device 150 may cycle the current that is sent to an electrode of a pair of electrodes (e.g., an electrode of electrodes 122 and a REM pad) through a range of frequencies, such as between 1 kilohertz (kHz) and 100 kHz, in order for system 100 to measure bipolar impedance between the pair of electrodes. For example, generator and sensing device 150 may cycle the current from 2 kHz, to 4 kHz, to 8 kHz, to 16 kHz, to 32 kHz, to 64 kHz, to 32 kHz, to 16 kHz, to 8 kHz, to 4 kHz, to 2 kHz, or any other suitable frequency range that are below RF ablation frequencies. Generator and sensing device 150 may cause catheter 112 to perform a cyclical low-power frequency sweet over a frequency range that is below RF ablation frequency, which may typically be above 150 kHz, as such a high RF frequency may wash out anatomical differences that can be identified by measuring the impedance values. At each frequency, processing circuitry 152 and / or processing circuitry 142 may measure the voltage drop between the electrode and the REM paid, and may use Ohm’s law (e.g., R = V / I) to determine the impedance value.
[0142] In some examples, processing circuitry 142 may output a first prompt via user interface 148 instructing a clinician to position catheter 112 in a first anatomical location, such as a renal artery. Upon receiving a first confirmation signal indicating that catheter 112 is positioned in the first anatomical location, processing circuitry 142 and / or processing circuitry 152 measures a first patient-specific baseline impedance profile associated with electrodes 122 and stores the first patient-specific baseline impedance profile in memory 144 and / or memory 154. Processing circuitry 142 may then output a second prompt via user interface 148 instructing the clinician to position catheter 112 in a second anatomical location, such as a hepatic artery. Upon receiving a second confirmation signal indicating that catheter 112 is positioned in the second anatomical location, processing circuitry 142 and / or processing circuitry 152 measures a second patient-specific baseline impedance profile associated with electrodes 122 and stores the second patient-specific baseline impedance profile in memory 144 and / or memory 154.
[0143] In some examples, system 100 further includes an imaging system 160 communicatively coupled to computing system 120. Imaging system 160 may comprise a fluoroscopy system, an angiography system, or any other suitable medical imaging modality configured to capture anatomical images of the patient. Imaging system 160 may beA0013546W001configured to generate and provide imaging data or a confirmation signal to computing system 120 indicative of a location of catheter 112 within the vasculature of the patient, which computing system 120 may display at user interface 148. For example, a clinician may utilize imaging system 160 to visually confirm that catheter 112 is positioned within a specific anatomical location, such as a renal artery or a hepatic artery, prior to initiating a baseline impedance calibration phase or delivering therapeutic ablation.
[0144] Computing system 120 may be configured to use the imaging data or the confirmation signal received from imaging system 160 in conjunction with impedance feedback or temperature feedback from catheter 112 to establish a patient-specific baseline profile for the confirmed anatomical location. In some examples, computing system 120 may output a prompt via user interface 148 instructing the clinician to position catheter 112 in a target vessel. Upon receiving the confirmation signal from imaging system 160, or via manual input through user interface 148 indicating that catheter 112 is successfully placed based on imaging from imaging system 160, processing circuitry 142 or processing circuitry 152 may record and tag the corresponding baseline impedance measurements to the confirmed anatomical location for use in subsequent location detection and treatment algorithms.
[0145] Following the completion of the pre-treatment calibration phase, the clinician may proceed with the therapeutic ablation procedure by navigating catheter 112 to a target anatomical location, such as the renal artery or the hepatic artery. Once catheter 112 is positioned at the intended target tissue site for ablation therapy, processing circuitry 142 and / or processing circuitry 152 may, prior to the start of energy delivery, such as during a time period immediately prior to the start of energy delivery, command electrodes 122 to obtain one or more live impedance measurements. The impedance measurements may measure bipolar impedance values between the same pairs of electrodes of electrodes 122 as during the pre-treatment calibration phase and / or monopolar impedance between the same electrode of electrodes 122 and each of one or more of the same REM pads placed on the same locations of the patient on the body of the patient as during the pre-treatment calibration phase. This impedance measurement may capture the current electrical and physiological characteristics of the tissue environment immediately surrounding electrodes 122, including the localized hemodynamics and the return path(s) to the one or more REM pads. If generator and sensing device 150 caused catheter 112 to perform a cyclical low-power frequency sweep during the pre-treatment calibration phase while measuring impedance values, generator and sensing device 150 may similarly cause catheter 112 to perform the same cyclical low-power frequency sweet while measuring the one or more live impedance measurements.A0013546W001
[0146] To verify that catheter 112 is correctly positioned within the intended target artery, processing circuitry 142 and / or processing circuitry 152 may compare the one or more live impedance measurement to the corresponding one or more impedance measurements of the previously stored patient-specific baseline impedance profiles. For example, if the clinician intends to perform a renal denervation procedure, processing circuitry 142 and / or processing circuitry 152 may retrieve the first patient-specific baseline impedance profile that was mapped specifically to the renal artery during the calibration phase. Processing circuitry 142 and / or processing circuitry 152 then evaluates the one or more impedance measurements against the corresponding one or more impedance measurements of this retrieved baseline profile to determine a degree of correlation or mathematical similarity, ensuring that the current procedural variables remain consistent with the established baseline.
[0147] If processing circuitry 142 and / or processing circuitry 152 determines that the one or more live impedance measurements fall within an acceptable tolerance (e.g., within 1%, within 3%, within 5%, etc.) or otherwise match the unique spatial fingerprint of the target patient-specific baseline impedance profile, processing circuitry 142 and / or processing circuitry 152 may confirm that catheter 112 is located in the correct target artery. Upon such a confirmation, processing circuitry 142 and / or processing circuitry 152 may output a verification signal, such as via user interface 148, indicating to the clinician that the location is verified. Processing circuitry 142 and / or processing circuitry 152 may therefore select the corresponding treatment algorithm and control electrodes 122 to deliver the therapeutic ablation. Similarly, if processing circuitry 142 and / or processing circuitry 152 determines that the one or more live impedance measurements deviate significantly from the expected patientspecific baseline impedance profile (e.g., being outside the acceptable tolerance), computing system 120 may output a visual or audible alert, such as via user interface 148, to warn the clinician of a potential misplacement or drift of catheter 112 before any ablative energy is delivered.
[0148] In some examples, instead of utilizing a pre-programmed, generalized renal ablation threshold or hepatic ablation threshold, computing system 120 may dynamically generate a patient-specific threshold based on the baseline impedance profiles obtained during the pre-treatment calibration phase. For example, processing circuitry 142 and / or processing circuitry 152 may utilize the stored first patient-specific baseline impedance profile to establish a customized renal ablation threshold tailored to the specific anatomy of the patient. Processing circuitry 142 and / or processing circuitry 152 may similarly utilize the stored second patient-specific baseline impedance profile to establish a customized hepatic ablationA0013546W001threshold. During the subsequent therapeutic ablation procedure, processing circuitry 142 and / or processing circuitry 152 may compare the live impedance feedback measured at electrodes 122 against these dynamically generated patient-specific thresholds to determine the location of catheter 112.
[0149] Additionally or alternatively, computing system 120 may utilize the stored first and second patient-specific baseline impedance profiles as inputs to train or dynamically adjust catheter location model 124. As previously described, catheter location model 124 stored in memory 144 and / or memory 154 may be a neural network algorithm trained via machine learning to determine the location of catheter 112. Processing circuitry 142 and / or processing circuitry 152 may feed the first and second patient-specific baseline impedance profiles into catheter location model 124 to adjust the node parameters or baseline weights of the neural network algorithm for the specific patient undergoing the procedure.
[0150] Once catheter location model 124 is calibrated with the patient-specific baseline data, processing circuitry 142 and / or processing circuitry 152 may input the live impedance feedback measured at electrodes 122 during the ablation procedure into the updated catheter location model 124. Catheter location model 124 may then output a highly personalized probability distribution indicating the likelihood that catheter 112 is located in the renal artery versus the hepatic artery, thereby allowing computing system 120 to select the appropriate treatment algorithm with increased accuracy and reduced risk of delivering off-target therapy.
[0151] FIG. 2 illustrates example energy pulses that can be used to determine the location of a medical catheter, in accordance with aspects of this disclosure. FIG. 2 is described with respect to system 100 of FIG. 1.
[0152] As shown in FIG. 2, graphs 200A and 200B illustrates two examples of RF pulses that electrodes 122 of catheter 112 may deliver. Processing circuitry 152 and / or memory 154 may receive impedance feedback and / or temperature feedback during and after the RF pulses, and may determine whether catheter 112 is located in a renal artery or a hepatic artery based on the received impedance feedback and / or temperature feedback. The RF pulse may be of a power level that is below that for therapeutic usage and / or tissue modifications. To deliver an RF pulse, electrodes 122 may deliver RF energy at a relatively lower power for a relatively longer period (e.g., a few seconds), deliver relatively higher power, below the threshold for therapeutic usage, for a relatively shorter time (e.g., one second or fewer), or may start with delivering a relatively lower-powered RF energy that is stilled up to a relatively higher-powered RF delivery.A0013546W001
[0153] In graph 200A, electrodes 122 may deliver RF pulse 202A by linearly increasing and then linearly decreasing RF energy for a short period of time (a few seconds), such as approximately 1 second, approximately 2 seconds, etc., before ramping up RF delivery 204 A to perform therapeutic ablation. Processing circuitry 152 and / or memory 154 may receive impedance feedback and / or temperature feedback measured during and after RF pulse 202A to determine, as electrodes 122 ramps up RF delivery 204 A, the location of catheter 112 and to select the appropriate therapeutic algorithm for controlling RF delivery 204A by catheter 112 to perform therapeutic ablation.
[0154] In graph 200B, electrodes 122 may deliver RF pulse 202B by delivering a RF pulse at a relatively lower power (e.g., 1 or 2 watts) and then stepping the RF pulse up to a relatively higher power (e.g., 2 to 5 watts), before ramping up RF delivery 204B to perform therapeutic ablation. Processing circuitry 152 and / or memory 154 may receive impedance feedback and / or temperature feedback measured during and after RF pulse 202B to determine, as electrodes 122 ramps up RF delivery 204B, the location of catheter 112 and to select the appropriate therapeutic algorithm for controlling RF delivery 204B by catheter 112 to perform therapeutic ablation.
[0155] FIG. 3 is a flow diagram illustrating an example technique for determining the location of a catheter using an RF pulse, in accordance with aspects of this disclosure. FIG. 3 is described with respect to system 100 of FIG. 1.
[0156] As shown in FIG. 3 processing circuitry 152 may be configured to communicate with drive circuitry 158 to electrically drive electrodes 122 to deliver an energy pulse (e.g., a RF pulse) to tissues to which electrodes 122 are apposed, prior to start of performing ablation therapy (302).
[0157] Processing circuitry 152 and / or processing circuitry 142 may be configured to receive temperature feedback and / or impedance feedback measured during and / or after delivery of the energy pulse from catheter 112 (304). The temperature feedback may include the temperatures measured at each of electrodes 122 during and after delivery of the energy pulse. The impedance feedback may include the impedances measured at each of electrodes 122 during and after delivery of the energy pulse.
[0158] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the temperature feedback, temperature information associated with the energy pulse, such as a rate of temperature increase or decrease from during delivery of energy pulse to after delivery of the energy pulse for each of electrodes 122, a magnitude of temperature change from during delivery of the energy pulse to after delivery of the energyA0013546W001pulse for each of electrodes 122, an average temperature from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122, and the like. Similarly, processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the impedance feedback, impedance information associated with the energy pulse, such as changes in impedance of each of electrodes 122 from during delivery of the energy pulse to after delivery of the energy pulse for each of electrodes 122.
[0159] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the temperature feedback and / or impedance feedback, the location of catheter 112 as being in one of a renal artery of the patient or a hepatic artery of the patient (306). In some examples, processing circuitry 152 and / or processing circuitry 142 may input the temperature information associated with the energy pulse and / or the impedance information associated with the energy pulse into catheter location model 124. Catheter location model 124 may be trained to use inputs, such as temperature information associated with the energy pulse and / or the impedance information associated with the energy pulse, as determined from the temperature feedback and / or impedance feedback measured during and / or after delivery of the energy pulse, to determine, based on the inputs, whether catheter 112 is located within a renal artery or a hepatic artery of the patient. Catheter location model 124 may therefore, based on the temperature information associated with the energy pulse and / or the impedance information associated with the energy pulse, output an indication of whether catheter 112 is located in a renal artery or in a hepatic artery of a patient.
[0160] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the temperature information associated with the energy pulse with a renal ablation threshold or a hepatic threshold to determine whether catheter 112 is located within a renal artery or within a hepatic artery. Similarly, in some examples, processing circuitry 152 and / or processing circuitry 142 may compare the impedance information associated with the energy pulse with a renal ablation threshold or a hepatic threshold to determine whether catheter 112 is located within a renal artery or within a hepatic artery.
[0161] Processing circuitry 152 and / or processing circuitry 142 may, select a treatment algorithm for electrodes 122 to perform therapeutic ablation based on the location of catheter 112 (308). If processing circuitry 152 and / or processing circuitry 142 determines that catheter 112 is located within a renal artery, processing circuitry 152 and / or processing circuitry 142 may select a renal treatment algorithm for catheter 112 to perform therapeutic ablation to treat the renal artery of the patient according to the renal treatment algorithm. Similarly, if processing circuitry 152 and / or processing circuitry 142 detects that catheter 112 is in aA0013546W001hepatic artery, memory 154 and / or processing circuitry 142 may select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation to treat the hepatic artery of the patient according to the hepatic treatment algorithm.
[0162] System 100 may therefore deliver ablation therapy to the patient according to the selected treatment algorithm (310). For example, if processing circuitry 152 and / or processing circuitry 142 detects that catheter 112 is in a hepatic artery, generator and sensing device 150 may control electrodes 122 of catheter 112 to perform therapeutic ablation to treat the hepatic artery according to the hepatic treatment algorithm. Similarly, if processing circuitry 152 and / or processing circuitry 142 detects that catheter 112 is in a renal artery, generator and sensing device 150 may control electrodes 122 of catheter 112 to perform therapeutic ablation to treat the renal artery according to the renal treatment algorithm.
[0163] FIG. 4 is a flow diagram illustrating an example technique for determining the location of a catheter based on feedback during an initial ramp of energy delivery, in accordance with aspects of this disclosure. FIG. 4 is described with respect to system 100 of FIG. 1.
[0164] As shown in FIG. 4 processing circuitry 152 may be configured to communicate with drive circuitry 158 to electrically drive electrodes 122 to ramp up energy delivery (e.g., RF delivery) to tissues to which electrodes 122 are apposed to begin therapeutic ablation (402).
[0165] Processing circuitry 152 and / or processing circuitry 142 may be configured to receive temperature feedback and / or impedance feedback measured during the initial ramp of energy (404). The temperature feedback may include the temperatures measured at each of electrodes 122 during the initial ramp. The impedance feedback may include the impedances measured at each of electrodes 122 during the initial ramp.
[0166] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the temperature feedback, temperature information during the initial ramp, such as a rate of temperature increase for each of electrodes 122, a magnitude of temperature increase for each of electrodes 122, an average temperature increase for each of electrodes 122, and the like. Similarly, processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the impedance feedback, impedance information during the initial ramp, such as changes in impedance of each of electrodes 122 during the initial ramp.
[0167] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the temperature feedback and / or impedance feedback, the location ofA0013546W001catheter 112 as being in one of a renal artery of the patient or a hepatic artery of the patient (406). In some examples, processing circuitry 152 and / or processing circuitry 142 may input the temperature information measured during the initial ramp and / or the impedance information measured during the initial ramp into catheter location model 124. Catheter location model 124 may be trained to use inputs, such as temperature information measured during the initial ramp and / or the impedance information measured during the initial ramp, as determined from the temperature feedback and / or impedance feedback, to determine, based on the inputs, whether catheter 112 is located within a renal artery or a hepatic artery of the patient. Catheter location model 124 may therefore, based on the temperature information and / or the impedance information, output an indication of whether catheter 112 is located in a renal artery or in a hepatic artery of a patient.
[0168] In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the temperature information measured during an initial ramp with a renal ablation threshold or a hepatic threshold to determine whether catheter 112 is located within a renal artery or within a hepatic artery. Similarly, in some examples, processing circuitry 152 and / or processing circuitry 142 may compare the impedance information measured during the initial ramp with a renal ablation threshold or a hepatic threshold to determine whether catheter 112 is located within a renal artery or within a hepatic artery.
[0169] Processing circuitry 152 and / or processing circuitry 142 may, select a treatment algorithm for electrodes 122 to perform therapeutic ablation based on the location of catheter 112 (408). If processing circuitry 152 and / or processing circuitry 142 determines that catheter 112 is located within a renal artery, processing circuitry 152 and / or processing circuitry 142 may select a renal treatment algorithm for catheter 112 to perform therapeutic ablation to treat the renal artery of the patient according to the renal treatment algorithm. Similarly, if processing circuitry 152 and / or processing circuitry 142 detects that catheter 112 is in a hepatic artery, memory 154 and / or processing circuitry 142 may select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation to treat the hepatic artery of the patient according to the hepatic treatment algorithm.
[0170] System 100 may therefore deliver ablation therapy to the patient according to the selected treatment algorithm (410). For example, if processing circuitry 152 and / or processing circuitry 142 detects that catheter 112 is in a hepatic artery, generator and sensing device 150 may control electrodes 122 of catheter 112 to perform therapeutic ablation to treat the hepatic artery according to the hepatic treatment algorithm. Similarly, if processing circuitry 152 and / or processing circuitry 142 detects that catheter 112 is in a renal artery, generator andA0013546W001sensing device 150 may control electrodes 122 of catheter 112 to perform therapeutic ablation to treat the renal artery according to the renal treatment algorithm.
[0171] FIG. 5 is a flow diagram illustrating an example technique for determining the location of a catheter based on feedback measured prior to the start of therapeutic ablation, in accordance with aspects of this disclosure. FIG. 5 is described with respect to system 100 of FIG. 1.
[0172] As shown in FIG. 5, processing circuitry 152 and / or processing circuitry 142 may be configured to receive impedance feedback measured during a time period immediately prior to the start of energy delivery (e.g., RF delivery) by catheter 112 to perform therapeutic ablation (502). The impedance feedback may include, for each electrode of electrodes 122, the impedance between the electrode and an REM pad placed on the patient.
[0173] In some examples, the impedance feedback may include bipolar impedance values between pairs of electrodes of electrodes 122. In some examples, catheter 112 may perform a cyclical low-power (e.g., approximately 1 watt of power) frequency sweep during measurement of bipolar impedance.
[0174] In examples where two REM pads are placed on the patient, the impedance feedback may include, for each electrode of electrodes 122, the impedance between the electrode and the first of the two REM pads placed on the patient and the impedance between the electrode and the second of the two REM pads placed on the patient. Processing circuitry 152 and / or processing circuitry 142 may measure impedance feedback, such as the measured impedance, of each of electrodes 122 for a period of time immediately prior to start of RF delivery by catheter 112, such as the preceding 10 seconds, preceding 20 seconds, and the like prior to the start of RF ablation.
[0175] Processing circuitry 152 and / or processing circuitry 142 are configured to determine, based on the impedance feedback, the location of catheter 112 as being in one of a renal artery of the patient or a hepatic artery of the patient (504). Processing circuitry 152 and / or processing circuitry 142 may determine the location of catheter 112 upon system 100 starting performance of therapeutic ablation of the patient via catheter 112.
[0176] In some examples, processing circuitry 152 and / or processing circuitry 142 may input the impedance information into catheter location model 124. Catheter location model 124 may be trained to use inputs, such as the impedance information measured in a time period immediately prior to the start of therapeutic ablation, to determine, based on the inputs, whether catheter 112 is located within a renal artery or a hepatic artery of the patient. Catheter location model 124 may therefore, based on the impedance information, output an indicationA0013546W001of whether catheter 112 is located in a renal artery or in a hepatic artery of a patient. In some examples, processing circuitry 152 and / or processing circuitry 142 may compare the impedance information with a renal ablation threshold or a hepatic threshold to determine whether catheter 112 is located within a renal artery or within a hepatic artery.
[0177] Processing circuitry 152 and / or processing circuitry 142 may, select a treatment algorithm for electrodes 122 to perform therapeutic ablation based on the location of catheter 112 (506). If processing circuitry 152 and / or processing circuitry 142 determines that catheter 112 is located within a renal artery, processing circuitry 152 and / or processing circuitry 142 may select a renal treatment algorithm for catheter 112 to perform therapeutic ablation to treat the renal artery of the patient according to the renal treatment algorithm. Similarly, if processing circuitry 152 and / or processing circuitry 142 detects that catheter 112 is in a hepatic artery, memory 154 and / or processing circuitry 142 may select a hepatic treatment algorithm for catheter 112 to perform therapeutic ablation to treat the hepatic artery of the patient according to the hepatic treatment algorithm.
[0178] System 100 may therefore deliver ablation therapy to the patient according to the selected treatment algorithm (508). For example, if processing circuitry 152 and / or processing circuitry 142 detects that catheter 112 is in a hepatic artery, generator and sensing device 150 may control electrodes 122 of catheter 112 to perform therapeutic ablation to treat the hepatic artery according to the hepatic treatment algorithm. Similarly, if processing circuitry 152 and / or processing circuitry 142 detects that catheter 112 is in a renal artery, generator and sensing device 150 may control electrodes 122 of catheter 112 to perform therapeutic ablation to treat the renal artery according to the renal treatment algorithm.
[0179] FIG. 6 is a flow diagram illustrating an example technique for determining the location of a catheter, in accordance with aspects of this disclosure. FIG. 6 is described with respect to system 100 of FIG. 1.
[0180] As shown in FIG. 6 processing circuitry 152 may be configured to communicate with drive circuitry 158 to electrically drive electrodes 122 to deliver an energy pulse (e.g., a RF pulse) to tissues to which electrodes 122 are apposed, prior to start of performing ablation therapy, and processing circuitry 152 and / or processing circuitry 142 may receive temperature feedback and / or impedance feedback measured during and / or after delivery of the energy pulse from catheter 112 (602). Alternatively, drive circuitry 158 may electrically drive electrodes 122 to ramp up energy delivery (e.g., RF delivery) to tissues to which electrodes 122 are apposed to begin therapeutic ablation, and processing circuitry 152 and / or processing circuitry 142 may receive temperature feedback and / or impedance feedback measured duringA0013546W001an initial ramp of energy delivery. The temperature feedback may include the temperatures measured at each of electrodes 122 during and after delivery of the energy pulse. The impedance feedback may include the impedances measured at each of electrodes 122 during and after delivery of the energy pulse.
[0181] Processing circuitry 152 and / or processing circuitry 142 are configured to determine whether the temperature information for all electrodes 122 are within a hepatic ablation threshold (604). In examples where temperatures of electrodes 122 are measured during and after delivery of an energy pulse, the temperature information may include a rate of temperature decrease from during delivery of energy pulse to after delivery of the energy pulse, a magnitude of temperature decrease from during delivery of the energy pulse to after delivery of the energy pulse, an average temperature from during delivery of the energy pulse to after delivery of the energy pulse, and the like. In examples where temperatures of electrodes 122 are measured during an initial ramp of energy delivery, the temperature information may include a rise in temperature over the initial ramp of energy delivery.
[0182] If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that the temperature information for all electrodes 122 are within a hepatic ablation threshold (YES at 604), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine that catheter 112 is located within a hepatic artery (606) and may select a hepatic treatment algorithm for performing ablation therapy of the hepatic artery (608).
[0183] If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that not all of the temperature information for electrodes 122 are within a hepatic ablation threshold (NO at 604), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine whether the temperature information for at least one active electrode of electrodes 122 is within a renal ablation threshold (610). If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that the temperature information for at least one active electrode of electrodes 122 is within a renal ablation threshold (YES at 610), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine that catheter 112 is located within a renal artery (612) and may select a renal treatment algorithm for performing ablation therapy of the renal artery (614).
[0184] If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that no temperature information for any active electrode of electrodes 122 is within a renal ablation threshold (NO at 610), processing circuitry 152 and / or processingA0013546W001circuitry processing circuitry 142 may determine whether the impedance signal for all electrodes 122 are within a hepatic ablation threshold (616). If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that the impedance information for all electrodes 122 are within a hepatic ablation threshold (YES at 616), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine that catheter 112 is located within a hepatic artery (606) and may select a hepatic treatment algorithm for performing ablation therapy of the hepatic artery (608).
[0185] If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that not all of the impedance information for electrodes 122 are within a hepatic ablation threshold (NO at 616), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine whether the impedance information for at least one active electrode of electrodes 122 is within a renal ablation threshold (618). If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that the impedance information for at least one active electrode of electrodes 122 is within a renal ablation threshold (YES at 618), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine that catheter 112 is located within a renal artery (612) and may select a renal treatment algorithm for performing ablation therapy of the renal artery (614).
[0186] In some examples, processing circuitry 152 and / or processing circuitry 142 may, after determining that catheter 112 is located within a renal artery and / or after selecting a renal treatment algorithm for performing ablation therapy of the renal artery, determine whether the temperature information for every active electrodes of electrodes 122 is within a renal ablation threshold. If processing circuitry 152 and / or processing circuitry 142 determines that the temperature information for every active electrodes of electrodes 122 is within a renal ablation threshold, processing circuitry 152 and / or processing circuitry 142 may continue treatment according to the renal treatment algorithm. If processing circuitry 152 and / or processing circuitry 142 determines that the temperature information for one or more of the active electrodes of electrodes 122 are not within a renal ablation threshold, processing circuitry 152 and / or processing circuitry 142 may turn off the one or more active electrodes having temperature information that are not within the renal ablation threshold.
[0187] FIG. 7 is a flow diagram illustrating an example technique for determining the location of a catheter based on feedback during an initial ramp of energy delivery, in accordance with aspects of this disclosure. FIG. 4 is described with respect to system 100 of FIG. 1.A0013546W001
[0188] As shown in FIG. 7, processing circuitry 152 and / or processing circuitry 142 may be configured to receive temperature feedback measured during the initial ramp of energy as drive circuitry 158 electrically drives electrodes 122 to ramp up energy delivery (e.g., RF delivery) to tissues to which electrodes 122 are apposed to begin therapeutic ablation (702).
[0189] Processing circuitry 152 and / or processing circuitry 142 are configured to determine whether the temperature information for all electrodes 122 are within a hepatic ablation threshold (704). In some examples, the temperature information may include a rise in temperature over the initial ramp of energy delivery.
[0190] If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that the temperature information for all electrodes 122 are within a hepatic ablation threshold (YES at 704), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine that catheter 112 is located within a hepatic artery (706) and may select a hepatic treatment algorithm for performing ablation therapy of the hepatic artery (708).
[0191] If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that not all of the temperature information for electrodes 122 are within a hepatic ablation threshold (NO at 704), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine whether the temperature information for at least one active electrode of electrodes 122 is within a renal ablation threshold (710). If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that the temperature information for at least one active electrode of electrodes 122 is within a renal ablation threshold (YES at 710), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine that catheter 112 is located within a renal artery (712) and may select a renal treatment algorithm for performing ablation therapy of the renal artery (714).
[0192] Processing circuitry 152 and / or processing circuitry 142 may, after determining that catheter 112 is located within a renal artery and / or after selecting a renal treatment algorithm for performing ablation therapy of the renal artery, determine whether the temperature information for every active electrodes of electrodes 122 is within a renal ablation threshold (716). If processing circuitry 152 and / or processing circuitry 142 determines that the temperature information for every active electrodes of electrodes 122 is within a renal ablation threshold (YES at 716), processing circuitry 152 and / or processing circuitry 142 may continue treatment according to the renal treatment algorithm (718). If processing circuitry 152 and / or processing circuitry 142 determines that the temperatureA0013546W001information for one or more of the active electrodes of electrodes 122 are not within a renal ablation threshold (NO at 716), processing circuitry 152 and / or processing circuitry 142 may turn off the one or more active electrodes having temperature information that are not within the renal ablation threshold (720).
[0193] FIG. 8 is a flow diagram illustrating an example technique for determining the location of a catheter based on feedback measured prior to the start of therapeutic ablation, in accordance with aspects of this disclosure. FIG. 8 is described with respect to system 100 of FIG. 1.
[0194] As shown in FIG. 8, processing circuitry 152 and / or processing circuitry 142 may be configured to receive impedance feedback measured during a time period immediately prior to the start of energy delivery (e.g., RF delivery) by catheter 112 to perform therapeutic ablation (802). The impedance feedback may include, for each electrode of electrodes 122, the impedance between the electrode and an REM pad placed on the patient.
[0195] In some examples, the impedance feedback may include bipolar impedance values between pairs of electrodes of electrodes 122. In some examples, catheter 112 may perform a cyclical low-power (e.g., approximately 1 watt of power) frequency sweep during measurement of bipolar impedance.
[0196] In examples where two REM pads are placed on the patient, the impedance feedback may include, for each electrode of electrodes 122, the impedance between the electrode and the first of the two REM pads placed on the patient and the impedance between the electrode and the second of the two REM pads placed on the patient. Processing circuitry 152 and / or processing circuitry 142 may measure impedance feedback, such as the measured impedance, of each of electrodes 122 for a period of time immediately prior to start of RF delivery by catheter 112, such as the preceding 10 seconds, preceding 20 seconds, and the like prior to the start of RF ablation.
[0197] Processing circuitry 152 and / or processing circuitry 142 are configured to determine whether the impedance measurements for electrodes 122 are within a hepatic ablation threshold (804). If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that the impedance measurements for electrodes 122 are within a hepatic ablation threshold (YES at 804), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine that catheter 112 is located within a hepatic artery (806) and may select a hepatic treatment algorithm for performing ablation therapy of the hepatic artery (808).A0013546W001
[0198] If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that the impedance measurements for electrodes 122 are not within a hepatic ablation threshold (NO at 804), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine whether the impedance measurements for electrodes 122 are within a renal ablation threshold (810). If processing circuitry 152 and / or processing circuitry processing circuitry 142 determines that the impedance measurements for electrodes 122 are within a renal ablation threshold (YES at 810), processing circuitry 152 and / or processing circuitry processing circuitry 142 may determine that catheter 112 is located within a renal artery (812) and may select a renal treatment algorithm for performing ablation therapy of the renal artery (814).
[0199] In some examples, system 100 may use a renal catheter to perform renal ablation and may use a multi-organ denervation (MDN) catheter to perform both renal ablation and hepatic ablation.
[0200] FIG. 9 is a flow diagram illustrating an example technique for determining the catheter for performing ablation therapy, in accordance with aspects of this disclosure. FIG. 9 is described with respect to system 100 of FIG. 1.
[0201] As shown in FIG. 9, processing circuitry 152 and / or processing circuitry 142 may determine that catheter 112 is located in the hepatic artery (902). Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located in the hepatic artery, determine whether catheter 112 is a MDN catheter plugged into generator and sensing device 150 (904). If processing circuitry 152 and / or processing circuitry 142 determines that catheter 112 is a MDN catheter plugged into generator and sensing device 150 ( YES at 904), processing circuitry 152 and / or processing circuitry 142 may select a hepatic treatment algorithm for catheter 112 to perform ablation therapy of the hepatic artery (906). If processing circuitry 152 and / or processing circuitry 142 determines that catheter 112 is not a MDN catheter plugged into generator and sensing device 150 ( NO at 904), processing circuitry 152 and / or processing circuitry 142 may output an error, such at user interface 148 (908).
[0202] FIG. 10 is a flow diagram illustrating an example technique for determining the catheter for performing ablation therapy, in accordance with aspects of this disclosure. FIG.10 is described with respect to system 100 of FIG. 1.
[0203] As shown in FIG. 10, processing circuitry 152 and / or processing circuitry 142 may determine that catheter 112 is located in the renal artery (1002). Processing circuitry 152 and / or processing circuitry 142 may, in response to determining that catheter 112 is located inA0013546W001the renal artery, determine whether catheter 112 is a renal catheter plugged into generator and sensing device 150 (1004). If processing circuitry 152 and / or processing circuitry 142 determines that catheter 112 is a renal catheter plugged into generator and sensing device 150 ( YES at 1004), processing circuitry 152 and / or processing circuitry 142 may select a renal treatment algorithm for catheter 112 to perform ablation therapy of the renal artery (1006). If processing circuitry 152 and / or processing circuitry 142 determines that catheter 112 is not a renal catheter plugged into generator and sensing device 150 ( NO at 1004), processing circuitry 152 and / or processing circuitry 142 may output an error, such as at user interface 148 (1008).
[0204] FIG. 11 is a flow diagram illustrating an example technique for determining the location of a catheter. FIG. 11 is described with respect to FIGS. 1 and 2.
[0205] As shown in FIG. 11, processing circuitry 142 of programmer 140 and / or processing circuitry 152 of generator and sensing device 150 may receive at least one of temperature feedback or impedance feedback associated with electrodes 122 of catheter 112( 1102).
[0206] Processing circuitry 142 and / or processing circuitry 152 may determine, based on at least one of the temperature feedback or the impedance feedback, a location of the catheter 112 within the patient (1104).
[0207] Processing circuitry 142 and / or processing circuitry 152 may select, based on the location of the catheter 112, a treatment algorithm for delivering therapeutic ablation (1106).
[0208] Processing circuitry 142 and / or processing circuitry 152 may control the electrodes 122 of the catheter 112 to deliver the therapeutic ablation according to the treatment algorithm (1108).
[0209] FIG. 12 illustrates an example technique for accessing a renal artery and modulating renal nerves with a neuromodulation catheter. While FIG. 12 illustrates the use of catheter 12 for renal neuromodulation, catheter 12 may be used for other therapies and treatments within another blood vessel or other hollow anatomical body within the human body. Catheter 12 is an example of catheter 112 of FIG. 1 and is configured to deliver energy (e.g., RF energy, ultrasound energy, electrical stimulation energy, or the like) to one or more target tissue sites within a renal vessel. Catheter 12 provides access to the renal plexus (RP) through an intravascular path (P), such as a percutaneous access site in the femoral (illustrated), brachial, radial, or axillary artery to the target tissue sites within a respective renal artery (RA). By manipulating proximal portion 22B or elongate body 22 from outside the intravascular path (P), a clinician may advance distal portion 22A of elongate body 22A0013546W001through the sometimes-tortuous intravascular path (P) and remotely manipulate distal portion 22A of elongate body 22. Distal portion 22A may be remotely manipulated by the clinician using handle 20.
[0210] In the example illustrated in FIG. 12, distal portion 22A is delivered intravascularly to the treatment site using an inner member 123 in an over-the-wire (OTW) technique. Inner member 123 may be internal to catheter 12 (e.g., a guide wire, inner catheter, or the like) or external to catheter 12 (e.g., an outer sheath or the like). In some examples, inner member 123 is a navigation wire. Catheter 12 may define a passageway for receiving inner member 23 for delivery of catheter 12 using either an OTW or an RX technique. At the treatment site, inner member 123 can be at least partially withdrawn or removed relative to catheter 12 and distal portion 22A can transform into an expanded configuration (for example, a helical configuration, a spiral configuration, or the like) for delivering ultrasound energy. In other examples, elongate body 22 is self-steerable such that therapy may be delivered to the target tissue site without the aid of inner member 123.
[0211] In some examples, catheters described herein may be used to perform renal modulation. Renal modulation is the partial or complete incapacitation or other effective disruption of nerves of the kidneys (e.g., nerves terminating in the kidneys or in structures closely associated with the kidneys). In particular, renal neuromodulation can include inhibiting, reducing, or blocking neural communication along neural fibers (e.g., efferent or afferent neural fibers) of the kidneys. Such incapacitation can be long-term (e.g., permanent or for a period of months, years, or decades) or short-term (e.g., for periods of minutes, hours, days, or weeks). Renal neuromodulation is expected to contribute to the systemic reduction of sympathetic tone or drive or benefit at least some specific organs or other bodily structures innervated by sympathetic nerves. Accordingly, renal neuromodulation is expected to be useful in treating clinical conditions associated with central sympathetic overstimulation. For example, renal neuromodulation is expected to efficaciously treat hypertension, heart failure, acute myocardial infarction, metabolic syndrome, insulin resistance, diabetes, left ventricular hypertrophy, chronic and end state renal disease, inappropriate fluid retention in heart failure, cardio-renal syndrome, polycystic kidney disease, polycystic ovary syndrome, osteoporosis, erectile dysfunction, and sudden death, among other conditions.
[0212] Renal neuromodulation can be electrically induced or induced in another suitable manner through the delivery of energy (RF energy, ultrasound energy, microwave energy, or the like). The target tissue site can be within or otherwise proximate to a renal lumen (e.g., a renal artery, a ureter, a renal pelvis, a major renal calyx, a minor renal calyx, or anotherA0013546W001suitable structure), and the target tissue site can include tissue at least proximate to a wall of the renal lumen. For example, with regard to a renal artery, a treatment procedure can include modulating nerves in the renal plexus, which lay intimately within or adjacent to the adventitia of the renal artery. The following discussion provides further details regarding patient anatomy and physiology as it may relate to renal denervation therapy. This section is intended to supplement and expand upon the previous discussion regarding the relevant anatomy and physiology, and to provide additional context regarding the disclosed technology and the therapeutic benefits associated with renal denervation. For example, several properties of the renal vasculature may inform the design of the target tissue devices and associated methods for achieving renal neuromodulation via intravascular access and impose specific design requirements for such devices. Specific design requirements may include accessing the renal artery, positioning distal portion 22A within the renal artery, delivering the therapy to targeted tissue, or effectively modulating the renal nerves with the therapy delivery device.
[0213] As noted previously, the sympathetic nervous system (SNS) is a branch of the autonomic nervous system along with the enteric nervous system and parasympathetic nervous system. It is always active at a basal level (called sympathetic tone) and becomes more active during times of stress. Like other parts of the nervous system, the sympathetic nervous system operated through a series of interconnected neurons. Sympathetic neurons are frequently considered part of the peripheral nervous system (PNS), although many lie within the central nervous system (CNS). Sympathetic neurons of the spinal cord (which is part of the CNS) communicate with peripheral sympathetic neurons via a series of sympathetic ganglia. Within the ganglia, spinal cord sympathetic neurons are therefore called presynaptic (or preganglionic) neurons, while peripheral sympathetic neurons are called postsynaptic (or postganglionic neurons).
[0214] At synapses within the sympathetic ganglia, preganglionic sympathetic neurons release acetylcholine, a chemical messenger that binds and activates nicotinic acetylcholine receptors on postganglionic neurons. In response to this stimulus, postganglionic neurons principally release noradrenaline (norepinephrine). Prolonged activation may elicit the release of adrenaline from the adrenal medulla.
[0215] Once released, norepinephrine and epinephrine bind adrenergic receptors on peripheral tissues. Binding to adrenergic receptors causes a neuronal and hormonal response. The physiologic manifestations include pupil dilation, increased heart rate, occasionalA0013546W001vomiting, and increased blood pressure. Increased sweating is also seen due to binding of cholinergic receptors of the sweat glands.
[0216] The sympathetic nervous system is responsible for up- and down-regulating many homeostatic mechanisms in living organisms. Fibers from the SNS innervate tissues in almost every organ system, providing at least some regulatory function to physiological features as diverse as pupil diameter, gut motility, and urinary output. This response is also known as sympatho-adrenal response of the body, as the preganglionic sympathetic fibers that end in the adrenal medulla (but also all other sympathetic fibers) secrete acetylcholine, which activates the secretion of adrenaline (epinephrine) and to a lesser extent noradrenaline (norepinephrine). Therefore, this response that acts primarily on the cardiovascular system is mediated directly via impulses transmitted through the sympathetic nervous system and indirectly via catecholamines secreted from the adrenal medulla.
[0217] FIG. 13 is a conceptual illustration of an example sympathetic nervous system (SNS) illustrating how the brain communicates with the body via the SNS. As shown in FIG.13, the SNS provides a network of nerves that allows the brain to communicate with the body. Sympathetic nerves originate inside the vertebral column, e.g., toward the middle of the spinal cord in the intermediolateral cell column (or lateral horn), beginning at the first thoracic segment of the spinal cord and are thought to extend to the second or third lumbar segments. Because SNS cells begin in the thoracic and lumbar regions of the spinal cord, the SNS is said to have a thoracolumbar outflow. Axons of sympathetic nerves leave the spinal cord through the anterior rootlet / root. The axons pass near the spinal (sensory) ganglion, where the axons enter the anterior rami of the spinal nerves. However, unlike somatic innervation, the axons separate out through white rami connectors which connect to either the paravertebral (which lie near the vertebral column) or prevertebral (which lie near the aortic bifurcation) ganglia extending alongside the spinal column.
[0218] To reach the target organs and glands, the axons should travel long distances in the body, and, to accomplish this, many axons relay their message to a second cell through synaptic transmission. The ends of the axons link across a space, the synapse, to the dendrites of the second cell. The first cell (the presynaptic cell) sends a neurotransmitter across the synaptic cleft where it activates the second cell (the postsynaptic cell). The message is then carried to the final destination.
[0219] In the SNS and other component of the peripheral nervous system, these synapses are made at sites called ganglia, discussed above. The cell that sends its fiber to the ganglion is called a preganglionic cell, while the cell whose fiber leaves the ganglion is called aA0013546W001postganglionic cell. As mentioned previously, the preganglionic cell of the SNS is located between the first thoracic (Tl) segment and third lumbar (L3) segments of the spinal cord. Postganglionic cells have their cell bodies in the ganglia and send their axons to target organs or glands.
[0220] The ganglia include not just the sympathetic trunks but also the cervical ganglia (superior, middle, and inferior), which send sympathetic nerve fibers to the head and thorax organs, and the celiac and mesenteric ganglia, which send sympathetic fibers to the gut.
[0221] FIG. 14 is an enlarged anatomic view of nerves innervating a left kidney to form the renal plexus surrounding the left renal artery. As FIG. 14 shows, the kidney is innervated by the renal plexus (RP), which is intimately associated with the renal artery. The renal plexus (RP) is an autonomic plexus that surrounds the renal artery and is embedded within the adventitia of the renal artery. The renal plexus (RP) extends along the renal artery and is embedded within the adventitia of the renal artery. Fibers contributing to the renal plexus (RP) arise from the celiac ganglion, the superior mesenteric ganglion, the aorticorenal ganglion and the aortic plexus. The renal plexus (RP), also referred to as the renal nerve, is predominantly comprised of sympathetic components. There is no (or at least very minimal) parasympathetic innervation of the kidney.
[0222] Preganglionic neuronal cell bodies are located in the intermediolateral cell column of the spinal cord. Preganglionic axons pass through the paravertebral ganglia to become the lesser splanchnic nerve, the least splanchnic nerve, the first lumbar splanchnic nerve, the second lumbar splanchnic nerve, and travel to the celiac ganglion, the superior mesenteric ganglion, and the aorticorenal ganglion. Postganglionic neuronal cell bodies exit the celiac ganglion, the superior mesenteric ganglion, and the aorticorenal ganglion to the renal plexus (RP) and are distributed to the renal vasculature.
[0223] Messages travel through the SNS in a bi-directional flow. Efferent messages may trigger changes in different parts of the body simultaneously. For example, the sympathetic nervous system may accelerate heart rate, widen bronchial passages, decrease motility (movement) of the large intestine, constrict blood vessels, increase peristalsis in the esophagus, cause pupil dilation, piloerection (goose bumps) and perspiration (sweating), or raise blood pressure. Afferent messages carry signals from various organs and sensory receptors in the body to other organs and, particularly, the brain.
[0224] Hypertension, heart failure, and chronic kidney disease are a few of the many disease states that result from chronic activation of the SNS, especially the renal sympathetic nervous system. Chronic activation of the SNS is a maladaptive response that drives theA0013546W001progression of theses disease states. Pharmaceutical management of the renin-angiotensin-aldosterone system (RAAS) has been a longstanding, but somewhat ineffective, approach for reducing over-activity of the SNS.
[0225] As mentioned above, the renal sympathetic nervous system has been identified as a major contributor to the complex pathophysiology of hypertension, states of volume overload (such as heart failure) and progressive renal disease, both experimentally and in humans. Studies employing radiotracer dilution methodology to measure overflow of norepinephrine from the kidneys to plasma revealed increased renal norepinephrine (NE) spillover rates in patients with essential hypertension, particularly so in young hypertensive subjects, which in concert with increased NE spillover from the heart, is consistent with the hemodynamic profile typically seen in early hypertension and characterized by an increased heart rate, cardiac output, and renovascular resistance. It is now known that essential hypertension is commonly neurogenic, often accompanied by pronounced sympathetic nervous system overactivity.
[0226] Activation of cardiorenal sympathetic nerve activity is even more pronounced in heart failure, as demonstrated by an exaggerated increase of NE overflow from the heart and the kidneys to plasma in this patient group. In line with this notion is the recent demonstration of a strong negative predictive value of renal sympathetic activation on allcause mortality and heart transplantation in patients with congestive heart failure, which is independent of overall sympathetic activity, glomerular filtration late, and left ventricular ejection fraction. These findings support the notion that treatment regimens that are designed to reduce renal sympathetic stimulation have the potential to improve survival in patients with heart failure.
[0227] Both chronic and end state renal disease in some patients are characterized by heightened sympathetic nervous activation. In patients with end state renal disease, plasma levels of norepinephrine above the media have been demonstrated to be predictive for both all-cause death and death from cardiovascular disease. This can also be true for patients suffering from diabetic or contrast nephropathy. There is compelling evidence suggesting that sensory afferent signals originating from the diseased kidneys are major contributors to initiating and sustaining elevated central sympathetic outflow in this patient group; this facilitates the occurrence of the well-known adverse consequences of chronic sympathetic over activity, such as hypertension, left ventricular hypertrophy, ventricular arrhythmias, sudden cardiac death, insulin resistance, diabetes, and metabolic syndrome.A0013546W001
[0228] Sympathetic nerves to the kidneys terminate in the blood vessels, the juxtaglomerular apparatus, and the renal tubules. Stimulation of the renal sympathetic nerves cause increased renin release, increased sodium (Na+) reabsorption, and a reduction of renal blood flow. These components of the neural regulation of renal function are considerably stimulated in disease states characterized by heightened sympathetic tone and clearly contribute to the rise in blood pressure in hypertensive patients. The reduction of renal blood flow and glomerular filtration rate as a result of renal sympathetic efferent stimulation may be a cornerstone of the loss of renal function in cardio-renal syndrome, which is renal dysfunction as a progressive complication of chronic heart failure, with a clinical course that typically fluctuates with the patient’s clinical status and treatment. Pharmacologic strategies to thwart the consequences of renal efferent sympathetic stimulation include centrally acting sympatholytic drugs, beta blockers (intended to reduce renin release), angiotensin converting enzyme inhibitors and receptor blockers (intended to block the action of angiotensin II and aldosterone activation consequent to renin release), and diuretics (intended to counter the renal sympathetic mediated sodium and water retention). However, the current pharmacologic strategies can have significant limitations including limited efficacy, compliance issues, side effects, and others.
[0229] The kidneys communicate with integral structures in the central nervous system via renal sensory afferent nerves. Several forms of “renal injury” may induce activation of sensory afferent signals. For example, renal ischemia, reduction in stroke volume or renal blood flow, or an abundance of adenosine enzyme may trigger activation of afferent neural communication.
[0230] FIG. 15 is an anatomic view of a human body depicting neural efferent and afferent communication between the brain and kidneys. FIG. 16 is a conceptual view of a human body depicting neural efferent and afferent communication between the brain and kidneys. As shown in FIGS. 15 and 16, the afferent communication might be from kidney to the brain or might be from one kidney to the other kidney (via the central nervous system). These afferent signals are centrally integrated and may result in increased sympathetic outflow. This sympathetic drive is directed towards the kidneys, thereby activating the RAAS and inducing increased renin secretion, sodium retention, volume retention, and vasoconstriction. Central sympathetic over activity also impacts other organs and bodily structures innervated by sympathetic nerves such as the heart and the peripheral vasculature, resulting in the described adverse effects of sympathetic activation, several aspects of which also contribute to the rise in blood pressure.A0013546W001
[0231] The physiology therefore suggests that (i) modulation of tissue with efferent sympathetic nerves will reduce inappropriate renin release, salt retention, and reduction of renal blood flow, and that (ii) modulation of tissue with afferent sensory nerves will reduce the systemic contribution to hypertension and other disease states associated with increased central sympathetic tone through its direct effect on the posterior hypothalamus as well as the contralateral kidney. In addition to the central hypotensive effects of afferent renal denervation, a desirable reduction of central sympathetic outflow to various other sympathetically innervated organs such as the heart and the vasculature is anticipated.
[0232] As provided above, renal denervation is likely to be valuable in the treatment of several clinical conditions characterized by increased overall and particularly renal sympathetic activity such as hypertension, metabolic syndrome, insulin resistance, diabetes, left ventricular hypertrophy, chronic end state renal disease, inappropriate fluid retention in heart failure, cardio-renal syndrome and sudden death. Since the reduction of afferent neural signals contributing to the systemic reduction of sympathetic tone / drive, renal denervation might also be useful in treating other conditions associated with systemic sympathetic hyperactivity. Accordingly, renal denervation may also benefit other organs and bodily structures innervated by sympathetic nerves, including those identified in FIG. 9. For example, as previously discussed, a reduction in central sympathetic drive may reduce the insulin resistance that afflicts people with metabolic syndrome and Type II diabetics.Additionally, patients with osteoporosis may also be sympathetically activated and might also benefit from the down regulation of sympathetic drive that accompanies renal denervation.
[0233] In accordance with the present technology neuromodulation of a left or right renal plexus (RP), which is intimately associated with a left or right renal artery, may be achieved through intravascular access. FIG. 17 is an anatomic view of the arterial vasculature of a human. As FIG. 17 shows, blood moved by contractions of the heart is conveyed from the left ventricle of the heart by the aorta. The aorta descends through the thorax and branches into the left and right renal arteries. Below the renal arteries, the aorta bifurcates at the left and right iliac arteries. The left and right iliac arteries descend, respectively, through the left and right legs and join the left and right femoral arteries.
[0234] FIG. 18 is an anatomic view of the venous vasculature of a human. As FIG. 18 shows, the blood collects in veins and returns to the heart, through the femoral veins into the iliac veins and into the inferior vena cava. The inferior vena cava branches into the left and right renal veins. Above the renal veins, the inferior vena cava ascends to convey blood into the right atrium of the heart. From the right atrium, the blood is pumped through the rightA0013546W001ventricle into the lungs, where it is oxygenated. From the lungs, the oxygenated blood is conveyed into the left atrium. From the left atrium, the oxygenated blood is conveyed by the left ventricle back to the aorta.
[0235] The femoral artery may be accessed and cannulated at the base on the femoral triangle just inferior to the midpoint of the inguinal ligament. A catheter may be inserted percutaneously into the femoral artery through this access site, passed through the iliac artery and aorta, and placed into either the left or right renal artery. This comprises an intravascular path that offers minimally invasive access to a respective renal artery or other renal blood vessels.
[0236] The wrist, upper arm, and shoulder region provide other locations for introduction of catheters into the arterial system. For example, catheterization of either the radial, brachial, or axillary artery may be utilized in select cases. Catheters (e.g., catheter 12) introduced via these access points may be passed through the subclavian artery on the left side (or via the subclavian and brachiocephalic arteries on the right side), through the aortic arch, down the descending aorta and into the renal arteries using standard angiographic techniques. Other access sites can also be used to access the arterial system.
[0237] Since neuromodulation of a left or right renal plexus (RP) may be achieved in accordance with the present technology through intravascular access, properties and characteristics of the renal vasculature may impose constraints upon or inform the design of apparatus, systems, and methods for achieving such renal neuromodulation. Some of these properties and characteristics may vary across the patient population or within a specific patient across time, as well as in response to disease states, such as hypertension, chronic kidney disease, vascular disease, end-stage renal disease, insulin resistance, diabetes, metabolic syndrome, and the like. These properties and characteristics, as explained herein, may have bearing on the efficacy of the procedure and the specific design of the intravascular device. Properties of interest may include, for example, material / mechanical, spatial, fluid dynamic / hemodynamic or thermodynamic properties.
[0238] As discussed previously, a catheter may be advanced percutaneously into either the left or right renal artery via a minimally invasive intravascular path. However, minimally invasive renal arterial access may be challenging, for example, because as compared to some other arteries that are routinely accessed using catheters, the renal arteries are often extremely tortuous, may be of relatively small diameter, or may be of relatively short length.Furthermore, renal arterial atherosclerosis is common in many patients, particularly those with cardiovascular disease. Renal arterial anatomy also may vary significantly from patient toA0013546W001patient, which further complicates minimally invasive access. Significant inter-patient variation may be seen, for example, in relative tortuosity, diameter, length, or atherosclerotic plaque burden, as well as in the take-off angle at which a renal artery branches from the aorta. Further, some patients include multiple left renal arteries or right renal arteries. Apparatus, systems, and methods for achieving renal neuromodulation via intravascular access should account for these and other aspects of renal arterial anatomy and its variation across the patient population when minimally invasively accessing a renal artery.
[0239] In addition to complicating renal arterial access, specifics of the renal anatomy also complicate establishment of stable contact between neuromodulatory apparatus and a luminal surface or wall of a renal artery. For example, navigation can be impeded by the tight space within a renal artery, as well as tortuosity of the artery. Furthermore, establishing consistent contact is complicated by patient movement, respiration, or the cardiac cycle because these factors may cause significant movement of the renal artery relative to the aorta, and the cardiac cycle may transiently distend the renal artery (i.e., cause the wall of the artery to pulse).
[0240] The neuromodulation system may also be configured to allow for adjustable positioning and repositioning of distal portion 22A (FIG. 12) within the renal artery since location of treatment may also impact clinical efficacy. Additionally, variable positioning and repositioning of the neuromodulatory apparatus may prove to be useful in circumstances where the renal artery is particularly tortuous or where there are proximal branch vessels off the renal artery main vessel, making treatment in certain locations challenging.
[0241] As noted above, an apparatus positioned within a renal artery may be configured so that distal portion 22A of catheter 12 may intimately contact the vessel wall or extend at least partially through the vessel wall. Renal artery vessel diameter, DRA, typically is in a range of about 2-10 mm, with most of the patient population having a DRA of about 4 mm to about 8 mm and an average of about 6 mm. Renal artery vessel length, LRA, between its ostium at the aorta / renal artery juncture and its distal branchings, generally is in a range of about 5-70 mm, and a significant portion of the patient population is in a range of about 20-50 mm. Since the target renal plexus is embedded within the adventitia of the renal artery, the composite Intima-Media Thickness, IMT, (i.e., the radial outward distance from the artery's luminal surface to the adventitia containing target neural structures) also is notable and generally is in a range of about 0.5-2.5 mm, with an average of about 1.5 mm. Although a certain depth of treatment is important to reach the target neural fibers, the treatment shouldA0013546W001not be too deep (e.g., > 10 mm from inner wall of the artery) to avoid non-target tissue and anatomical structures such as anatomical structures of the digestive system of psoas muscle.
[0242] An additional property of the renal artery that may be of interest is the degree of renal motion relative to the aorta induced by respiration or blood flow pulsatility. A patient’s kidney, which is located at the distal end of the renal artery, may move as much as 10 centimeters cranially with respiratory excursion. This may impart significant motion to the renal artery connecting the aorta and the kidney, thereby requiring from the neuromodulatory apparatus a unique balance of stiffness and flexibility to maintain contact between the energy delivery element and the vessel wall during cycles of respiration. Furthermore, the take-off angle between the renal artery and aorta may vary significantly between patients, and also may vary dynamically within a patient, e.g., due to kidney motion. The take-off angle generally may be in a range of about 30°-135°.
[0243] In general, the devices, systems, and techniques described herein may be used in conjunction with neuromodulation performed from within any suitable anatomical lumen that has nerves adjacent to the anatomical lumen. Example anatomical lumens include the celiac trunk and its branches (including the common hepatic artery and its branches, the gastroduodenal artery and its branches, the right gastric artery and its branches, and the proper hepatic artery and its branches, the left gastric artery and its branches, and the splenic artery and its branches), the superior mesenteric artery and its branches, the gonadal artery and its branches, the inferior mesenteric artery and its branches, and the like. Further, although the disclosure primarily describes neuromodulation from within one or more arteries, the devices, systems, and techniques of the disclosure also may be applied to neuromodulation from within one or more veins, such as a renal vein and its branches, a hepatic vein and its branches, an intercostal vein and its branches, or the like.
[0244] In some implementations, the devices, systems, and techniques described herein may be used to perform neuromodulation from within two or more anatomical lumens, e.g., in the renal arteries and the common hepatic artery, or any other combination of two or more anatomical lumens, either simultaneously or sequentially. In addition, the systems, devices, and methods described herein may be useful in conjunction with neuromodulation within a body lumen other than a vessel, for extravascular neuromodulation and / or for use in conjunction with therapies other than neuromodulation.
[0245] The techniques described in this disclosure may be implemented, at least in part, in hardware, software, firmware, or any combination thereof. For example, various aspects of the described techniques may be implemented within processing circuitry, including one orA0013546W001more microprocessors, digital signal processors (DSPs), application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or any other equivalent integrated or discrete logic circuitry, as well as any combinations of such components. The term "processor" or "processing circuitry" may generally refer to any of the foregoing logic circuitry, alone or in combination with other logic circuitry, or any other equivalent circuitry. A control unit including hardware may also perform one or more of the techniques of this disclosure.
[0246] Such hardware, software, and firmware may be implemented within the same device or within separate devices to support the various techniques described in this disclosure. In addition, any of the described instructions, units, modules or components may be implemented together or separately as discrete but interoperable logic devices. Depiction of different features as modules or units is intended to highlight different functional aspects and does not necessarily imply that such modules or units must be realized by separate hardware, firmware, or software components. Rather, functionality associated with one or more modules or units may be performed by separate hardware, firmware, or software components, or integrated within common or separate hardware, firmware, or software components.
[0247] The techniques described in this disclosure may also be embodied or encoded in a computer system-readable medium, such as a computer system-readable storage medium, containing instructions. Instructions embedded or encoded in a computer system-readable medium, including a computer system-readable storage medium, may cause one or more programmable processors, or other processors, to implement one or more of the techniques described herein, such as when instructions included or encoded in the computer system- readable medium are executed by the processing circuitry. Computer system readable storage media may include random access memory (RAM), read only memory (ROM), programmable read only memory (PROM), erasable programmable read only memory (EPROM), electronically erasable programmable read only memory (EEPROM), flash memory, a hard disk, a compact disc ROM (CD-ROM), a floppy disk, a cassette, magnetic media, optical media, or other computer system readable media. In some examples, an article of manufacture may comprise one or more computer system-readable storage media, for example, non-transitory computer system-readable storage media.
[0248] Various examples have been described. These and other examples are within the scope of the following claims.
Claims
A0013546W001CLAIMS1. A method comprising:receiving, by processing circuitry, at least one of temperature feedback or impedance feedback associated with electrodes of a catheter;determining, by the processing circuitry and based on at least one of the temperature feedback or the impedance feedback, a location of the catheter within a patient;selecting, by the processing circuitry and based on the location of the catheter, a treatment algorithm for delivering therapeutic ablation; andcontrolling, by the processing circuitry, the electrodes of the catheter to deliver the therapeutic ablation according to the treatment algorithm.
2. The method of claim 1, wherein determining the location of the catheter within the patient further comprises:determining, by the processing circuitry and based on at least one of the temperature feedback or the impedance feedback, the location of the catheter as being within one of a renal artery of the patient or a hepatic artery of the patient3. The method of any of claims 1 and 2,wherein the temperature feedback includes temperature measurements at the electrodes during an initial ramp of energy delivery by the catheter to perform the therapeutic ablation, andwherein the impedance feedback includes impedance measurements at the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation.
4. The method of claim 3, wherein determining the location of the catheter further comprises:determining, by the processing circuitry and based on the temperature measurements at the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, the location of the catheter within the patient.A0013546W0015. The method of claim 4, wherein determining the location of the catheter further comprises:determining, by the processing circuitry and based on the temperature measurements at the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, rises in temperatures of the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation; anddetermining, by the processing circuitry and based on the rises in temperatures of the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, the location of the catheter within the patient.
6. The method of any of claims 3-5, wherein determining the location of the catheter further comprises:determining, by the processing circuitry and based on the temperature measurements and the impedance measurements at the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, the location of the catheter within the patient.
7. The method of any of claims 1 and 2, wherein the impedance feedback includes impedance measurements for each of the electrodes during an initial ramp of energy delivery by the catheter to perform the therapeutic ablation, and wherein determining the location of the catheter further comprises:determining, by the processing circuitry and based on the impedance measurements for each of the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, the location of the catheter within the patient.
8. The method of claim 7, wherein the impedance measurements for each of the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation include, for each of the electrodes, a first impedance measurement between the electrode and a first ground pad placed at a first location on the patient’s body and a second impedance measurement between the electrode and a second ground pad placed at a second location on the patient’s body.A0013546W0019. The method of claim 8, wherein the first ground pad is a first return electrode monitoring (REM) pad, and wherein the second ground pad is a second REM pad.
10. The method of any of claims 1 and 2, wherein the impedance feedback includes impedance measurements at the electrodes during a time period that immediately precedes initiation of the therapeutic ablation by the catheter.
11. The method of claim 10, wherein the impedance feedback includes bipolar impedance values of pairs of the electrodes.
12. The method of claim 11, further comprising:performing, by the processing circuitry, a cyclical frequency sweep of the electrodes during measurement of the bipolar impedance values of the pairs of the electrodes.
13. The method of any of claims 1 and 2, further comprising:controlling, by the processing circuitry, the electrodes of the catheter to deliver an energy pulse prior to delivering the therapeutic ablation,wherein the temperature feedback includes temperature measurements at the electrodes during and after the electrodes deliver the energy pulse, andwherein the impedance feedback includes impedance measurements at the electrodes during and after the electrodes deliver the energy pulse.
14. The method of claim 13, wherein determining the location of the catheter within the patient further comprises:determining, by the processing circuitry and based on the temperature measurements at the electrodes during and after the electrodes deliver the energy pulse, one or more of: magnitudes of temperature change of the electrodes after the energy pulse or rates of temperature change of the electrodes after the energy pulse;determining, by the processing circuitry, and based on one or more of the magnitudes of temperature changes of the electrodes after the energy pulse or the rates of temperature changes of the electrodes after the energy pulse, the location of the catheter within the patient.A0013546W00115. The method of any of claims 13 and 14 wherein determining the location of the catheter within the patient further comprises:determining, by the processing circuitry and based on the impedance measurements at the electrodes during and after the electrodes deliver the energy pulse, changes in the impedance measurements of the electrodes from during the energy pulse to after the energy pulse;determining, by the processing circuitry, and based on the changes in the impedance measurements of the electrodes, the location of the catheter within the patient.
16. The method of any of claims 1-15, further comprising:controlling, by the processing circuitry, the electrodes of the catheter to deliver an additional energy pulse while delivering the therapeutic ablation;determining, by the processing circuitry, additional rates of temperature changes of the electrodes after the additional energy pulse; anddetermine, by the processing circuitry, that the catheter is not well-apposed to tissues of a vessel based on the additional rates of temperature changes of the electrodes after the additional energy pulse; andbased on determining that the catheter is not well-apposed, increasing, by the processing circuitry, a power of energy delivered via the electrodes.
17. The method of any of claims 1-16, wherein determining the location of the catheter further comprises:inputting, by the processing circuitry, at least one of the temperature feedback or the impedance feedback, into one or more neural networks trained via machine learning to determine, based on at least one of the temperature feedback or the impedance feedback, the location of the catheter within the patient.
18. The method of any of claims 2-17,wherein determining the location of the catheter comprises determining, by the processing circuitry, that the location of the catheter is the renal artery of the patient, andA0013546W001wherein selecting, based on the location of the catheter, the treatment algorithm for delivering the therapeutic ablation further comprises selecting, by the processing circuitry and based on the location of the catheter being the renal artery of the patient, a renal treatment algorithm for delivering the therapeutic ablation to the renal artery of the patient.
19. The method of any of claims 2-17,wherein determining the location of the catheter comprises determining, by the processing circuitry, that the location of the catheter is the hepatic artery of the patient, and wherein selecting, based on the location of the catheter, the treatment algorithm for delivering the therapeutic ablation further comprises selecting, by the processing circuitry and based on the location of the catheter being the hepatic artery of the patient, a hepatic treatment algorithm for delivering the therapeutic ablation to the hepatic artery of the patient.
20. A system comprising:memory;processing circuitry coupled to the memory and configured to:receive at least one of temperature feedback or impedance feedback associated with electrodes of a catheter;determine, based on at least one of the temperature feedback or the impedance feedback, a location of the catheter within a patient;select, based on the location of the catheter, a treatment algorithm for delivering therapeutic ablation; andcontrol the electrodes of the catheter to deliver the therapeutic ablation according to the treatment algorithm.
21. The system of claim 20, wherein to determine the location of the catheter within the patient, the processing circuitry is further configured to:determine, based on at least one of the temperature feedback or the impedance feedback, the location of the catheter as being within one of a renal artery of the patient or a hepatic artery of the patient.
22. The system of any of claims 20 and 21,A0013546W001wherein the temperature feedback includes temperature measurements at the electrodes during an initial ramp of energy delivery by the catheter to perform the therapeutic ablation, andwherein the impedance feedback includes impedance measurements at the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation.
23. The system of claim 22, wherein to determine the location of the catheter, the processing circuitry is further configured to:determine, based on the temperature measurements at the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, the location of the catheter within the patient.
24. The system of claim 23, wherein to determine the location of the catheter, the processing circuitry is further configured to:determine, based on the temperature measurements at the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, rises in temperatures of the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation; anddetermine, based on the rises in temperatures of the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, the location of the catheter within the patient.
25. The system of any of claims 22-24, wherein to determine the location of the catheter, the processing circuitry is further configured to:determine, based on the temperature measurements and the impedance measurements at the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, the location of the catheter within the patient.
26. The system of any of claims 20 and 21, wherein the impedance feedback includes impedance measurements for each of the electrodes during an initial ramp of energy delivery by the catheter to perform the therapeutic ablation, and wherein to determine the location of the catheter, the processing circuitry is further configured to:A0013546W001determine, based on the impedance measurements for each of the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation, the location of the catheter within the patient.
27. The system of claim 26, wherein the impedance measurements for each of the electrodes during the initial ramp of energy delivery by the catheter to perform the therapeutic ablation include, for each of the electrodes, a first impedance measurement between the electrode and a first ground pad placed at a first location on the patient’s body and a second impedance measurement between the electrode and a second ground pad placed at a second location on the patient’s body.
28. The system of claim 27, wherein the first ground pad is a first return electrode monitoring (REM) pad, and wherein the second ground pad is a second REM pad.
29. The system of any of claims 20 and 21, wherein the impedance feedback includes impedance measurements at the electrodes during a time period that immediately precedes initiation of the therapeutic ablation by the catheter.
30. The system of claim 29, wherein the impedance feedback includes bipolar impedance values of pairs of the electrodes.
31. The system of claim 30, wherein the processing circuitry is further configured to:perform a cyclical frequency sweep of the electrodes during measurement of the bipolar impedance values of the pairs of the electrodes.
32. The system of any of claims 20 and 21, wherein the processing circuitry is further configured to:control the electrodes of the catheter to deliver an energy pulse prior to delivering the therapeutic ablation,wherein the temperature feedback includes temperature measurements at the electrodes during and after the electrodes deliver the energy pulse, andwherein the impedance feedback includes impedance measurements at the electrodes during and after the electrodes deliver the energy pulse.A0013546W00133. The system of claim 32, wherein to determine the location of the catheter within the patient, the processing circuitry is further configured to:determine, based on the temperature measurements at the electrodes during and after the electrodes deliver the energy pulse, one or more of: magnitudes of temperature changes of the electrodes after the energy pulse or rates of temperature changes of the electrodes after the energy pulse;determine, based on one or more of: the magnitudes of temperature changes of the electrodes after the energy pulse or the rates of temperature changes of the electrodes after the energy pulse, the location of the catheter within the patient.
34. The system of any of claims 32 and 33, wherein to determine the location of the catheter within the patient, the processing circuitry is further configured to:determine, based on the impedance measurements at the electrodes during and after the electrodes deliver the energy pulse, changes in the impedance measurements of the electrodes from during the energy pulse to after the energy pulse;determine, based on the changes in the impedance measurements of the electrodes, the location of the catheter within the patient.
35. The system of any of claims 20-34, wherein the processing circuitry is further configured to:control the electrodes of the catheter to deliver an additional energy pulse while delivering the therapeutic ablation;determine additional rates of temperature changes of the electrodes after the additional energy pulse; anddetermine that the catheter is not well-apposed to tissues of a vessel based on the additional rates of temperature changes of the electrodes after the additional energy pulse; and based on determining that the catheter is not well-apposed, increase a power of energy delivered by the electrodes.
36. The system of any of claims 20-35, wherein to determine the location of the catheter, the processing circuitry is further configured to:A0013546W001input at least one of the temperature feedback or the impedance feedback, into one or more neural networks trained via machine learning to determine, based on at least one of the temperature feedback or the impedance feedback, the location of the catheter within the patient.
37. The system of any of claims 21-36,wherein to determine the location of the catheter, the processing circuitry is configured to determine that the location of the catheter is the renal artery of the patient, and wherein to select, based on the location of the catheter, the treatment algorithm for delivering the therapeutic ablation, the processing circuitry is configured to select, based on the location of the catheter being the renal artery of the patient, a renal treatment algorithm for delivering the therapeutic ablation to the renal artery of the patient.
38. The system of any of claims 21-36,wherein to determine the location of the catheter, the processing circuitry is configured to determine that the location of the catheter is the hepatic artery of the patient, andwherein to select, based on the location of the catheter, the treatment algorithm for delivering the therapeutic ablation, the processing circuitry is configured to select, based on the location of the catheter being the hepatic artery of the patient, a hepatic treatment algorithm for delivering the therapeutic ablation to the hepatic artery of the patient.
39. An apparatus comprising means for performing the method of any of claims 1-19.
40. A non-transitory computer readable storage medium comprising instructions that, when executed by processing circuitry, cause the processing circuitry to perform the method of any of claims 1-19.
